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FOREWORD
T
ype 2 diabetes is one of the most significant public health challenges of our time, and 
affects around 2.8 million people in england. It can lead to blindness, kidney failure and 
limb loss, it contributes to greater risks of heart attack, heart failure and stroke, and it is 
associated with compromise to life expectancy. the cost of caring for people with type 2 
diabetes and its complications has been estimated to consume around 10% of the nhS budget. the 
number of people affected is increasing year-on-year. the most important single modifiable risk 
factor is being overweight or obese. But there is much that can be done. 
We have recently entered the first phase of national roll out of the healthier You: nhS Diabetes 
Prevention Programme, the first type 2 diabetes prevention programme to be implemented 
nationally. this is exclusively for people at high risk of developing ype 2 diabetes, those with what 
is termed “non-diabetic hyperglycaemia”. 
For those that already have the disease we are focussing on tackling variation in achievement of 
treatment targets for glucose, blood pressure and cholesterol, and are promoting better access to 
structured education for people newly diagnosed, all supported by the new Clinical Commissioning 
Group Improvement and Assessment Framework. 
Research supported by the nIhR has contributed significantly to the evidence behind these 
national programmes.
Research from the nIhR is continuing to evolve evidence around lifestyle interventions and 
their effect to delay or prevent the onset of type 2 diabetes. We also know much more about the 
importance of everyday good care to live well with diabetes. Research has shown how structured 
care and education can help, but we know from the national Diabetes Audit that not everyone 
is getting this. this review provides a useful round-up of evidence which should help those 
commissioning, providing and using diabetes services. We have seen how published research has 
shaped our work on prevention, monitoring and management of the disease. It is also good to 
see major trials underway of promising interventions from new physical activity programmes 
to treatments for diabetes-related eye disease. At the same time, qualitative research helps 
explain why people might not attend education sessions and what approaches work for different 
populations. We need all of this research to help drive best practice to deliver our shared goal of 
improving the lives of all those touched by type 2 diabetes.
Professor Jonathan Valabhji,
national Clinical Director for Obesity and Diabetes, nhS england 
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T
his review brings together recent evidence 
from research which may be of interest to 
those delivering, planning or using diabetes 
services. It focuses on studies funded by the 
national Institute for health Research (nIhR). the 
nIhR was set up in 2006 as the research arm of the 
nhS to provide a health research system focused 
on the needs of patients and the public.  Over the 
last ten years, the nIhR has funded a number of 
programmes, projects, research centres, work  
streams and researchers working in diabetes 
prevention, management and care. evidence  
from these different studies has not been brought  
together in this way before. 
this is not a comprehensive review of all 
research findings in diabetes, which is a vast area 
of knowledge and practice. It complements other 
initiatives, including the comprehensive public health 
and clinical guidelines provided by the national 
Institute for health and Care excellence (nICe), 
and other policy initiatives to improve diabetes 
prevention and care.
this review focuses on type 2 diabetes, which 
makes up more than 90% of all cases of diabetes.  
Unless stated otherwise, all references to diabetes in 
this report are to type 2 diabetes. the issues around 
type 1 diabetes with onset from early childhood 
are distinct and fall outside the scope of this report. 
however, we do touch on the growing issue of 
younger adults with type 2 diabetes. 
this review gives a short account of completed and 
ongoing nIhR-funded studies on diabetes and how 
they have informed practice. More information on 
this research is available in the Appendices, and many 
full reports and protocols can also be downloaded at 
the nIhR Journals Library website. 
Unless otherwise stated, all research mentioned 
in this report is funded entirely or substantively by 
nIhR, or the researcher or research centre has been 
supported through nIhR infrastructure or fellowship 
funding.
Our hope is that this represents an accessible 
digest of nIhR research on type 2 diabetes and forms 
both a useful summary for people wishing to see an 
overview and a starting point for those wishing to 
know more. 
WHaT Is THIs REvIEW?
AbbreviAtions used frequently  
in this review:
GP General Practitioner
HbA1c Glycated haemoglobin (a test that 
indicates blood glucose levels over  
a period of time)
NHS  national health Service
NICE the national Institute for health  
and Care excellence
NIHR national Institute for health Research
SIGN Scottish Intercollegiate Guidelines 
network
whAt is type 2 diAbetes?
Diabetes is a long term condition that causes a 
person’s blood sugar level to become too high. 
this can lead to a number of health problems.
Sugar levels in the blood are controlled by 
the hormone insulin which is produced by the 
pancreas.
there are two main types of diabetes:
 » In type 1 diabetes the pancreas doesn’t 
produce any insulin.
 » In type 2 diabetes either the pancreas doesn’t 
produce enough insulin or the body’s cells 
don’t react normally to insulin.
this review is about type 2 diabetes.
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preventing type 2 diAbetes in people  
At risk
 » Lifestyle interventions to change diet and activity 
work in delaying or preventing diabetes in those  
at risk.
 » For people with impaired glucose tolerance, 
walking for just 20 minutes a day over a year 
reduces cardiovascular risk.
 » new diabetes prevention programmes are building 
on nIhR research, from tools to identify those at 
risk to programmes of activity and education.
 » new trials are testing promising approaches to 
prevention, from recruiting people with diabetes 
as mentors to providing education and activity 
programmes for those at risk.
 » For those who are very overweight, bariatric 
surgery reduces the risk of developing type 2 
diabetes fourfold over seven years. this surgery 
can even lead to remission of diabetes in around a 
third of obese people with the condition. 
 » ‘One size fits all’ social marketing campaigns or 
interventions may not work to prevent diabetes, 
owing to diverse cultural beliefs and traditions.
 » With more people developing type 2 diabetes at an 
early age, research efforts are underway to identify 
the best ways of preventing the condition in young 
people. 
identifying people with type 2 diAbetes
 » For people at high risk, hbA1c rather than fasting 
glucose is better for assessing vascular risk. 
 » evidence does not support screening for diabetes 
in the general population.
 » Where screening is considered appropriate (such as 
in high risk populations), using a risk stratification 
tool followed by a screening blood test is the most 
cost-effective approach.
delivering CAre And reduCing the risk 
of CompliCAtions
 » It is safe for people found to be at low risk to have 
their eyes checked for diabetic retinopathy every 
three years, rather than every year – a finding 
which has reduced costs and may be better for 
patients.
 » the most cost-effective way of testing people with 
diabetes for kidney disease is to measure albumin 
to creatinine ratio in the urine.
 » new technologies may help detect complications 
and reduce costs, as shown in automated detection 
of macular oedema (one form of diabetes-related 
eye disease). 
self-mAnAgement
 » Structured education can work but few 
attend, particularly those at greatest risk of 
complications. Research shows more explanation 
and encouragement by health professionals would 
make a difference to patients. Follow-up after an 
initial session is also important.
 » early research suggests computer-based packages 
could help patients manage their diabetes and 
mobile phone apps may also be helpful.
 » Group clinics – currently more popular in the US 
than here – show promise as a means of offering 
patients better access to specialist care with the 
benefits of peer support.
 » Patients value personalised care plans and 
treatment targets.
 » Breaking up sedentary time with even short bouts 
of activity can help improve metabolic health, both 
for people with diabetes and those at risk.
 » Self-monitoring of blood glucose levels for patients 
with type 2 diabetes who are not on insulin has 
only a small impact and is unlikely to be cost-
effective.
EvIDENCE HIGHLIGHTs
Here we highlight just some of the findings from nIhR research which have helped to shape diabetes policy and practice. Details of all the studies in this report are given in the Appendices.
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preventing type 2 diAbetes in people  
At risk
 » Are we consistent in how we identify people at risk 
in our locality, using agreed tools and risk scores?
 » Do we know how to refer patients to the local 
diabetes prevention programme and what services 
are on offer?
 » For people with obesity, what is the provision and 
uptake of bariatric surgery in our area compared 
with others?
 » If I am at risk, am I doing all that I can to prevent 
diabetes and related complications – for instance, 
walking an extra 20 minutes a day?
identifying people with type 2 diAbetes
 » Are we using hbA1c rather than fasting plasma 
glucose to detect diabetes in people judged to be 
at high risk after health checks? 
 » Am I in a group at higher risk of having type 2 
diabetes? Should I get tested?
delivering CAre And reduCing the risk 
of CompliCAtions
 » how well are we delivering standard care processes 
across our area compared with others in the 
national audit?
 » Are we consistently achieving all three nICe 
treatment targets (glucose, blood pressure and 
cholesterol control) in the majority of people with 
type 2 diabetes?
 » how can we improve our call and recall service 
and patient attendance for diabetic retinopathy 
screening?
 » have we considered automating to check for 
macular oedema in people with diabetes?
 » have we looked at ways of improving monitoring 
and routine care for patients? Could group clinics 
with a full team of health professionals work here?
 » have I been for my regular diabetes checks? Do I 
know when and how to get my eyes and feet seen? 
 » how could I give advice on healthy eating and 
staying active to people who have just been 
diagnosed or are at risk of diabetes?
WHaT DOEs THIs MEaN FOR ME?
T
his evidence raises questions that you and your organisation may want to consider in order to improve 
the care of people with diabetes or those at risk of developing it. these questions do not cover all 
aspects of care (as given in nICe guidance) but are prompted by the particular research studies featured 
in this review. 
Our questions are aimed at everyone concerned with type 2 diabetes: patients, commissioners, managers, 
GPs, community nurses, and other professionals working in diabetes care. Some particular questions for people 
with type 2 diabetes, or those at risk, are shown in blue.
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self-mAnAgement
 » Are we commissioning structured patient 
education that meets national standards? Does this 
include some form of follow-up or reinforcement?
 » Do we know who attends education sessions?  
Do we understand the reasons why patients do  
not attend, and have we got a plan to tackle this?
 » have we tailored sessions to meet the needs of our 
population, for instance appropriate dietary advice 
for different groups?
 » Are GPs and practice nurses clear about the 
education programmes we offer and are they able 
to describe the benefits to patients?
 » What sort of ongoing support is offered to 
patients? Is there flexibility to accommodate 
different patient needs and preferences?
 » When did I last attend a patient education 
programme? Should I find out if this is available 
locally? 
 » has my GP or practice nurse asked about my 
personal treatment goals and discussed options for 
managing my diabetes with me?
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W
e know that diabetes is a major public 
health challenge. Over 4 million people 
in the UK live with type 2 diabetes 
and this number is rising year on year. 
We know that many people do not know they have 
diabetes, and many more are at risk of developing 
the disease. Weight is the most important risk factor 
for type 2 diabetes that can be changed. Yet two out 
of three adults in this country are now overweight 
or obese. We also know that type 2 diabetes affects 
some people more than others. For instance, South 
Asian and black communities are two to four times 
more likely to develop diabetes than others.
Diabetes is a serious condition, which can have 
devastating consequences for individuals and 
their families. It mainly affects adults, although is 
becoming increasingly common in younger age 
groups. there is an increased risk of complications 
particularly related to blood vessels – either 
‘macrovascular’ (affecting large blood vessels such 
as the coronary vessels, causing heart disease and 
stroke) or ‘microvascular’ (affecting small blood 
vessels such as those in the eye, kidney and nerves 
causing a wide range of other problems in the feet 
and elsewhere). having type 2 diabetes doubles 
the risk of such cardiovascular disease. It is the most 
common reason for severe kidney disease and the 
second most common cause of blindness in working 
age adults. Overall, it is estimated that type 2 
diabetes accounts for 22,000 premature deaths a  
year in england.
treating and managing the disease directly costs 
the health service around £10 billion each year. 
this is around a tenth of all health spend, and it is 
estimated that 80% of these costs are in treating 
complications which could be avoided. Regular checks 
and monitoring are critical to good type 2 diabetes 
care, but the national Diabetes Audit shows us that 
not everyone receives the care and checks they need 
to keep well. Similar findings are seen  
in reports describing quality of care for people with  
a diagnosis of diabetes in Scotland, Wales and  
northern Ireland. 
these statistics explain why national and local 
leaders have identified type 2 diabetes as a top 
priority for action and investment. the facts are 
compelling. But behind each fact are real life  
patient stories. 
Behind much of what we know now about how 
best to prevent and manage this disease is research 
of different kinds. this report highlights some of 
the research funded by nIhR along the patient 
pathway from prevention to early identification to 
management of the disease. We have illustrated 
aspects of this journey with comments and insights 
from a number of people using services and living 
with diabetes. 
WHy DOEs DIabETEs 
MaTTER?
When we think about the experience of someone with type 2 
diabetes, it is important to remember that the time we spend with 
healthcare professionals represents just a fraction of the total experience. 
For the rest of the time, we are very much on our own, so equipping us 
with the knowledge, skills and motivation to manage our conditions is 
always key to successful outcomes. 
robin swindell, london
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DIabETEs – a pRIORITy FOR EvERyONE
Diabetes is a global concern and a health priority in all parts of the UK. Important strategic initiatives 
range from an ambitious five-year vision for diabetes care in Wales in 2013 to a compelling study of 
variations in care in Scotland in 2015. A partnership approach to diabetes in northern Ireland was shared 
with stakeholders in 2016. 
In england, a framework in 2014 set out actions for commissioners to drive prevention and early 
detection of diabetes as well as better management of diabetes in primary care. these aims will be 
realised through local sustainability and transformation plans in every locality, including specific 
commitments to improve diabetes services. At the same time, a national diabetes prevention programme 
was launched in 2016, flagged in the Five Year Forward view, to roll out structured evidence-based 
support for those at risk in all parts of the country. 
USEfUl STRATEGIC RESoURCES
Action for diabetes (nhS england 2014):  
https://www.england.nhs.uk/wp-content/uploads/2014/01/act-for-diabetes.pdf 
together for health (Welsh Government 2013): http://gov.wales/docs/dhss/publications/130923diabetesen.pdf 
Age of Diabetes: health of the nation Report (Diabetes Scotland 2015): 
https://www.diabetes.org.uk/In_your_area/scotland/Diabetes_in_your_area_scotland/ 
Diabetes Strategic Framework Consultation (northern Ireland Department of health 2016):  
https://www.health-ni.gov.uk/consultations/diabetes-strategic-framework-consultation 
REaD MORE
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pREvENTING TypE 2 
DIabETEs IN pEOpLE  
aT RIsk
I think for me, personally, I started to think about what I’m putting 
in my mouth and I started to think about an increase in exercise. The 
pedometer was brilliant because it made me go out … I was doing zilch 
exercise, and it gave you that incentive to go for a fifteen minute walk on 
my lunch break. I started doing that, just to get my steps up. It made me 
change a lifestyle thing, change a habit into a good habit and then start 
doing more exercise. 
participant in activity programme
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whAt do we know?
a
round 5 million people in this country are 
at high risk of developing diabetes.  Risk 
factors include being overweight, taking 
little exercise and having high blood 
pressure and cholesterol levels. We know that being 
obese is the single most important modifiable risk 
factor (Public health england 2014). Much attention 
now is focused on doing what we can to identify and 
support healthier lifestyles in those at greatest risk.
We highlight some important nIhR studies, 
but these do not provide a complete overview of 
evidence on preventing diabetes. Comprehensive 
guidance is provided by nICe on diabetes prevention. 
this includes 2012 guidance for clinicians on 
identifying individuals at risk and referring them for 
lifestyle change interventions (nICe 2012 (Ph38)). 
earlier guidance on population and community-based 
interventions was targeted at commissioners (nICe 
2011 (Ph35)). 
there is good evidence that lifestyle interventions 
such as keeping to a healthy weight and staying 
active can greatly reduce or delay the onset of type 
2 diabetes. A review published in 2012 confirmed 
that structured diet and activity programmes were 
effective and cost-effective in reducing risk of disease 
progression. But this review also showed that not all 
people benefited to the same degree. health benefits 
were greatest when people stuck closely to the 
programme, but this was often hard to do. 
ReAD MORe (Study 1)
An important five year research programme 
assessed a staged approach to type 2 diabetes 
prevention in general practice. this included testing 
a new risk score which uses routine data held at the 
practice, followed by blood tests in those found to be 
at high risk. those found to have high glucose levels 
(but not high enough to be diagnosed with diabetes) 
were referred to structured group-based education 
and a support programme based on a successful 
model for people with established type 2 diabetes. 
this approach was evaluated in a trial which 
reported in 2016. It found that although there were 
benefits in patient health and wellbeing, there was 
no significant reduction in the number of people 
developing type 2 diabetes. however, for those 
attending all sessions, there was real impact with 
significant reductions in those developing the disease. 
A version of this programme is now being rolled out 
as part of the healthier You: nhS Diabetes Prevention 
Programme in england. 
ReAD MORe (Study 2)
Another ambitious ongoing study on diabetes 
prevention has a particular focus on increasing 
physical activity, building on earlier nIhR funded 
work (‘Walking Away from type 2 Diabetes’) showing 
that structured education with pedometer use can 
improve activity and health. this will be tested in 
a large randomised trial of over thirteen hundred 
individuals with a high risk of type 2 diabetes in two 
regions in england, half of whom will receive the 
intervention. 
the study will also test different levels of support, 
from intensive coaching by trained educators to 
text reminders around goals set by patients. People 
taking part will be followed up for four years to see 
whether the programme leads to sustained increases 
in physical activity and a reduced risk of diabetes. the 
cost-effectiveness of the different approaches will 
also be tested. 
ReAD MORe (Study 3)
I would love to see greater representation of diverse communities in 
all organisations that support the prevention, treatment and control of 
type 2 diabetes. Influential policy and patient organisations need to reach 
out to local community groups such as ours and individuals from diverse 
communities need to apply to get involved – that’s how change will 
happen. 
kirit mistry, leicester
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WaLk IT OFF? IMpaCT OF aCTIvITy pROGRaMME
A study analysing data from a group of over 9,000 people with impaired glucose tolerance (i.e. people 
at high risk of type 2 diabetes) found that increasing activity levels by 2,000 steps per day over a year led 
to an 8% reduction in the risk of cardiovascular disease or cardiovascular death over a five year period. 
two thousand steps per day equates to just 20 minutes of walking. this study was the first to quantify 
the importance of making simple and attainable changes to walking activity to the future cardiovascular 
health in those with a high risk of type 2 diabetes. 
ReAD MORe (Study 4)
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An interesting approach is being tested to train 
volunteers with established diabetes to coach, 
support and mentor those at risk of developing the 
disease. early findings suggested this approach was 
acceptable and feasible. these diabetes prevention 
mentors are now part of a larger seven year 
evaluation of a comprehensive diabetes prevention 
programme. this will also look to see if the mentors 
experience any improvement in their own diabetes 
control and health through participating in the 
programme. 
ReAD MORe (Study 5)
the nIhR has also funded a number of studies on 
the effectiveness of different approaches to change 
behaviour and encourage healthier lifestyles. not 
all of them are featured here, but one example 
is an initiative sited in football clubs, targeted at 
overweight men who were recruited through the 
club they support. Participants attended fitness and 
weight-loss sessions at the club and lost over 5kg 
more than a control group. the programme was 
structured to include behaviour change techniques 
known to be effective for improved physical activity 
and weight loss and many felt they had benefited 
from the camaraderie and support offered by the 
football club setting.
ReAD MORe (Study 6)
While much focus has been on behaviour change, 
other studies have looked at the effect of particular 
treatments to reduce weight on developing type 2 
diabetes. An nIhR-funded review in 2009 showed 
that bariatric (weight reducing) surgery was effective 
and cost-effective for moderately to severely obese 
people. 
More recently, a population-based cohort study of 
over 2,000 people undergoing surgery found that it 
reduced the risks of developing diabetes by four-fold 
for up to seven years after the operation. Looking at 
a wider dataset, this study also found that severely 
obese people who do not have surgery find it difficult 
to lose weight. Recent work by the same team has 
shown that, for around a third of people with obesity 
and type 2 diabetes, bariatric surgery can induce 
remission of diabetes. this effect was seen in patients 
followed up for six years after surgery. 
ReAD MORe (Study 7)
this section has considered research on strategies 
once people have been identified with established 
risk factors for diabetes. Other nIhR research 
has contributed to our understanding of healthy 
populations and mechanisms of prevention and 
development of disease, though this important 
upstream research is beyond the scope of this review. 
the nIhR also issued a call at the end of 2015 for new 
research on obesity prevention and management 
with a particular focus on preventing diabetes.  
Research is now underway which should add to what 
we know in this area.
ONE sIzE FITs aLL? 
TaILORING HEaLTH 
aDvICE 
People from black and minority ethnic groups 
have a much higher risk of developing type 
2 diabetes and experiencing complications. 
Prevention strategies need to take account of 
people’s knowledge, understanding and beliefs 
about developing the disease. these may be 
different in different communities. One research 
project in Leicester is working with diverse 
ethnic groups to inform a social marketing 
campaign to raise awareness of diabetes risk and 
prevention. 
ReAD MORe (Study 8)
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how hAs reseArCh helped deCision-
mAkers?
N
IhR research has helped us to establish 
that lifestyle interventions are effective in 
preventing and delaying the onset of type 
2 diabetes. this informed the move towards 
free checks of vascular risk and comprehensive nICe 
guidance on diabetes prevention for populations and 
individuals. this included use of risk scores developed 
and validated by nIhR funded work. 
nIhR research has also examined the way in which 
particular interventions to reduce weight, such as 
bariatric surgery, can reduce risks of developing the 
condition and may also be a treatment option for 
people with type 2 diabetes who are obese. 
 nIhR studies have looked at different ways of 
supporting healthier lifestyles for people identified as 
high risk. this includes evidence which is being tested 
more widely showing the impact of structured activity 
programmes on reducing cardiovascular risk for those 
at risk of diabetes. Other approaches being evaluated 
include use of diabetes prevention mentors to 
educate those at risk, and different kinds of coaching 
and support by health staff. Building on these 
approaches, this year the healthier You: nhS Diabetes 
Prevention Programme – an ambitious programme of 
structured patient education for those at risk of type 
2 diabetes – is being rolled out in england. nIhR is 
funding research to evaluate these services.  
there is encouraging evidence on the potential of 
structured lifestyle programmes to make a difference 
in preventing diabetes for those at risk. Research 
also shows us how hard it can be for individuals and 
populations to take these steps. It will be important 
to continue to share learning and identify emerging 
good practice from services to help people at risk of 
diabetes stay healthy for as long as possible. 
WHaT WORks? ORGaNIsING DIabETEs  
pREvENTION sERvICEs
the nIhR will be funding new research alongside the healthier You: nhS Diabetes Prevention 
Programme which is currently being rolled out in england.  Research is needed to generate early learning 
from sites which are trying out different ways of designing and delivering prevention programmes. For 
instance, an nIhR evaluation is underway on a programme in Salford which combines telephone support, 
exercise and targeted prevention work with hard to reach groups. this builds on previous work in 
Manchester to develop and test coaching and other support to change health behaviours. 
ReAD MORe (Study 9)
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More people are now developing type 2 diabetes 
at an early age. there is an increasing need to focus 
effort on healthy lifestyles for children and young 
people. A team in South London is conducting studies 
related to type 2 diabetes prevention in children. 
this includes work to develop and pilot interventions 
based on changes in diet and behaviour to prevent 
insulin resistance in children from ethnic groups at 
high risk for type 2 diabetes. 
ReAD MORe (Study 10)
Another group of researchers in London are 
emphasising the importance of considering all 
stages of life when tackling diabetes, particularly in 
communities that may be at higher risk.
One study is exploring factors influencing 
feeding practices of infants aged 6-24 months in 
the Bangladeshi community. these may be a driver 
for increased risk of type 2 diabetes, cardiovascular 
disease and obesity in adulthood. the aim is to 
inform a participatory health intervention to improve 
infant feeding practices in this community in tower 
hamlets.
ReAD MORe (Study 11)
there is also some important ongoing work 
studying the best ways of providing integrated 
community-based diabetes prevention and care 
services for children and young people in newham, 
which has high prevalence of type 2 diabetes in 
its youth population. this involves using action 
research to inform and influence the re-design of 
children and young people’s diabetic services and 
improve peer education, including the creation of 
‘Youth Commissioners’ who have contributed to the 
production of the commissioning guidance.
ReAD MORe (Study 12)
GET THEM yOuNG?  
pREvENTING TypE 2 DIabETEs IN CHILDREN
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IDENTIFyING pEOpLE 
WITH TypE 2 DIabETEs
THE NuMbER OF pEOpLE IN THE 
uk WHO HavE TypE 2 DIabETEs, 
buT DO NOT kNOW IT
THE INCREasED RIsk OF DEvELOpING 
subsEquENT TypE 2 DIabETEs FOR WOMEN 
WHO HavE DIabETEs IN pREGNaNCy
500,000
7x
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whAt do we know?
O
ver half a million people in this country 
have type 2 diabetes without knowing it. 
this matters, as some people already have 
complications when they are diagnosed, 
which could have been prevented. this might suggest 
that everyone should be screened for type 2 diabetes, 
but setting up an expensive national screening 
programme is not always the right thing to do. nIhR 
research has played an important part in this debate.
An ambitious international trial looked at this 
question. It took 20,000 people from practices in UK, 
netherlands and Denmark and allocated them to 
screening with intensive management, screening with 
usual management or no screening. Patients were 
followed up for almost ten years. the study showed 
problems in attendance for screening. even when 
type 2 diabetes was identified by screening, there was 
no benefit in reduced deaths. the study concluded 
there was no evidence to support general population 
screening. 
ReAD MORe (Study 13)
One of the main problems is that no perfect 
screening test exists. An earlier review suggested 
that screening using current tests would find more 
people with impaired glucose tolerance (pre-
diabetes) than with type 2 diabetes itself and that 
screening the general population would not prevent 
future complications. Screening was therefore not 
recommended. 
ReAD MORe (Study 14)
I thought I knew about diabetes. My father had had diabetes and 
was insulin-dependent so I had seen at first-hand how tricky it could be to 
manage the disease. 
As I got into my early sixties, though, with my husband being treated 
for cancer, life became very stressful. So much so that I put my frequent 
trips to the loo down to the stress, never thinking about the possibility 
of diabetes. Thank goodness, then, for GP screening for type 2, based 
on risk factors that include family history. I was called in for a blood test. 
My blood sugar showed up very high and off I went for another glucose 
tolerance test. This time type 2 diabetes was confirmed.
Jenny stevens, london
My GP said I should have known better. After all, I had cared for my 
mother, who had type 1 diabetes and needed a lot of support. So when  
I went to the doctor complaining of feeling persistently tired and thirsty,  
I think he expected me to already know that this was type 2 diabetes.
kirit mistry, leicester
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how hAs reseArCh helped deCision-
mAkers? 
W
e know that a significant number 
of people have undiagnosed type 
2 diabetes. We know that the nhS 
health check programme and other 
opportunistic screening efforts will detect some 
people with the condition. nIhR research has shown 
the benefits of using hbA1c over fasting blood 
glucose tests to assess vascular risks in people at high-
risk. But it has also shown that there is no evidence 
currently to justify general population screening. 
there is some uncertainty about whether early 
detection leads to longer term benefit. Ongoing 
research will explore the value of case finding in 
specific groups, such as those with learning disability.
LOOkING FOR DIabETEs? DOING MORE FOR pEOpLE 
WITH LEaRNING DIsabILITIEs
We know that people with learning disabilities tend to have poorer health, be more overweight, and  
be less active and could therefore be at greater risk of diabetes. But not much research has been done 
with this particular community. An nIhR funded study is developing and testing a structured screening 
and lifestyle intervention for early detection and management of diabetes for people with learning 
disabilities. this study will find the best ways of identifying those at risk, developing and evaluating a 
tailored programme with input from people with learning disabilities, carers and staff.
ReAD MORe (Study 18)
nIhR studies have, however, provided authoritative 
evidence around testing strategies. A recently 
published study in people over 40, who would be 
offered an nhS health check, provided categorical 
evidence that using haemoglobin A1c (hbA1c) 
to screen for type 2 diabetes was cost-effective 
compared with fasting plasma glucose for high-risk 
individuals. 
ReAD MORe (Study 15)
A further modelling study provided evidence 
on the cost-effectiveness of a range of different 
screening strategies by considering the cost per case 
identified of over 212 different combinations of 
tests. the study concluded screening a population 
using a non-invasive risk stratification tool followed 
by a screening blood test was the most cost-effective 
method of screening for type 2 diabetes and 
abnormal glucose tolerance.
ReAD MORe (Study 13)
Uptake of invitation-based screening for type 
2 diabetes is a barrier to identifying people with 
undiagnosed type 2 diabetes. A recent trial looked 
at opportunistic screening where either individuals 
were encouraged to fill in a self-assessment risk score 
when visiting a GP (for other reasons) or a computer-
based risk score was run through GP databases to 
flag individuals at risk. People identified would 
then be advised to book for a blood test next time 
they visited their GP. Both approaches successfully 
identified new people with type 2 diabetes, with 
the computer-based risk score potentially the 
most promising strategy as it resulted in greater 
attendance to an initial blood test when compared to 
the self-assessment score.
ReAD MORe (Study 16)
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ExpECTING THE bEsT?  
DEvELOpING DIabETEs DuRING pREGNaNCy
the number of women developing diabetes during pregnancy is increasing. Poorly controlled diabetes can 
lead to complications for mothers and babies. But having diabetes during pregnancy also increases the risk 
of developing subsequent type 2 diabetes about sevenfold. It is therefore important to identify these women 
early and give them appropriate support during pregnancy and after birth, given the window to prevent or 
delay later diabetes (although uptake of postnatal screening is poor). 
An ongoing nIhR funded study is reviewing best ways of screening and treating women with gestational 
diabetes. As part of this work, the team used population data to look at the association between glucose 
levels in pregnancy and birth outcomes in different ethnic groups. they found that lower fasting and post-load 
glucose thresholds improved accuracy in the diagnosis of gestational diabetes in South Asian women. these 
findings suggest that current nICe diagnostic criteria may underestimate the prevalence of gestational diabetes 
in this population. 
ReAD MORe (Study 17)
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DELIvERING CaRE aND 
REDuCING THE RIsk  
OF COMpLICaTIONs
INCREasED LIkELIHOOD OF HEaRT 
DIsEasE OR sTROkE IN aDuLTs WITH 
TypE 2 DIabETEs
pROpORTION OF pEOpLE WITH TypE 2 DIabETEs 
DyING OF kIDNEy DIsEasE
2 – 4 times 
that of people 
without diabetes
1/10
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whAt do we know?
R
egular monitoring of people with type 2 
diabetes is important, for example checking 
blood glucose and other factors such as 
blood pressure and cholesterol. General 
practitioners and nurses in primary care are central to 
delivering this routine care. the key aim is to prevent 
complications arising from compromised large or 
small blood vessels. these can lead to heart disease 
and problems with kidneys, eyes, nerves and feet. 
For this reason, standards have been introduced with 
nine key care processes. Although diabetes care has 
improved over the years, the national Diabetes Audit 
has shown that there is still variation in the uptake 
of these care processes in practice. One important 
finding is that younger, working age people with 
type 2 diabetes tend to receive fewer checks and have 
poorer outcomes than average.
At first I didn’t want to hear about the disease and how to control it, 
I just wanted it all to be reversed. But then I started to worry about the 
risks to my eyesight and the chances of losing my driving licence, which 
would have taken away my independence… I do make sure, now, that I 
get all the regular checks: eyes, feet and kidney function, as it’s vital to 
monitor these.
kirit mistry, leicester
My GP and I agreed that tackling my newly-diagnosed condition is a 
collaboration between him and me. He provides the metformin and the 
monitoring checks. I focus on the diet and exercise, keeping a record of 
when I have various tests done and all the results. I take these with me 
when I go to see him so we can review the pattern. I can discuss concerns 
with him at any time or use my judgement to wait until my six-monthly 
check-up…. 
So, to anyone who’s getting to grips with their type 2 diabetes, I 
would say this: work on the partnership with your GP. Talk to him or her 
about how the practice can support you to manage the condition. Take 
responsibility for your part in the management of your diabetes – find out 
what you need to know and track your tests and other indicators of your 
condition – and make sure you get all your important annual checks, such 
as foot care, and keep a record to remind you.
Jenny stevens, london
niCe type 2 diAbetes reCommended 
CAre proCesses 
 » Body mass index measurement
 » Blood pressure measurement
 » haemoglobin A1c (hbA1c) measurement
 » Cholesterol measurement
 » Record of smoking status
 » Foot examination
 » Urinary albumin to creatinine ratio
 » Serum creatinine measurement
 » eye examination
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this section covers research addressing particular 
aspects of treating and preventing complications 
arising from diabetes. the wider issue of how 
people with diabetes manage their disease day to 
day and how best to support them is covered in 
the next section. But the important care processes 
outlined here provide structured points of contact for 
patients with health services. two recent studies have 
looked at tools to give patients with diabetes more 
information before consultations to make better 
treatment choices. this includes a study in primary 
care focusing on decisions for people with type 2 
diabetes about when to start insulin.
ReAD MORe (Study 19)
A further study examined the value of using a 
patient decision aid to make treatment choices in 
general practice.
ReAD MORe (Study 20)
Given the increasing options and complexity of 
treatment choices in diabetes, this focus on shared 
decision-making is very welcome.  
A large study looked at whether early intensive 
management of people with type 2 diabetes 
reduced the risk of developing cardiovascular 
disease or other type 2 diabetes-related problems 
such as diabetic retinopathy. this trial included 
over three hundred GP practices in the UK, 
netherlands and Denmark. even though intensive 
treatment improved type 2 diabetes control 
compared with standard care, there was no 
significant reduction in cardiovascular events 
(cardiac arrests or stroke) or deaths after five 
years. this was partly because standard care for 
people with type 2 diabetes in these countries is 
now good, so the differences between this and 
the more intensive approach were not so great. 
A further study from this team modelled the 
potential effect over a longer period (ten years). 
this suggested that in the longer term, risk of 
cardiovascular disease may be reduced. 
ReAD MORe (Study 13)
As well as looking at the impact on 
cardiovascular risk, the study also investigated 
the impact of early intensive treatment on 
microvascular outcomes, relating to problems 
with the kidneys, eyes and nerves. Although there 
was a slightly higher risk of retinopathy for those 
receiving standard care, the difference was not so 
great as to support more intense treatment. 
ReAD MORe (Study 13)
Lowering blood glucose is an important part of 
reducing the risk of microvascular complications. 
nIhR studies have contributed to evidence on 
the effectiveness of blood glucose-lowering 
medication. this has included a number of 
technology assessment reports contributing to 
nICe guidance for clinical staff. For example, one 
review suggested that agents such as the ‘gliptins’ 
were clinically effective and cost-effective for 
blood glucose control in type 2 diabetes compared 
to existing treatments.
ReAD MORe (Study 21)
this is a rapidly changing area of research and 
large studies have been funded by pharmaceutical 
companies to evaluate newer drugs and their 
impact on cardiovascular events in people 
with type 2 diabetes. this includes the recently 
published non-nIhR eMPA-ReG OUtCOMe trial on 
sodium-glucose cotransporter 2 inhibitors (Wanner 
2016) and ‘LeADeR’ study on the effects of 
liraglutide (Marso 2016). nIhR funded studies can 
complement some of these large pharmaceutical 
trials by focusing on areas which may be less 
attractive to industry, including comparative 
effectiveness and cost-effectiveness studies of  
older drugs.
HEaRT aND CIRCuLaTION
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Diabetic retinopathy and diabetic macular 
oedema are important complications of type 2 
diabetes, both of which can lead to sight loss. 
Retinopathy is caused by high blood sugar levels 
damaging the back of the eye. this can get worse 
over time. At first, small vessels at the back of the 
eye (retina) can become blocked and leak small 
amounts of fluid or blood. this does not usually 
affect the sight and is known as background 
retinopathy. Over time though if enough blood 
vessels become blocked, new vessels start to grow 
and can cause significant bleeding. the retina 
can also detach from the back of the eye causing 
blindness.  
Many people with type 2 diabetes have no 
symptoms until retinopathy is advanced. For this 
reason, a national eye screening programme 
has been set up to identify patients with early 
eye problems. Skilled individuals working in GP 
practices, mobile units, opticians or hospital clinics 
take digital photographs and assess results. People 
with retinopathy are referred for assessment 
and treatment by specialists. People with type 2 
diabetes are currently invited for screening once a 
year unless background retinopathy was detected. 
But there was uncertainty about the optimal 
frequency of screening. this has big implications 
for the nhS, so nIhR studies were commissioned  
to address this.
One study used data from screening services 
and GPs to develop statistical models to test the 
cost-effectiveness of different screening intervals. 
the study found that continuing to do annual 
screening for people who have no indication of 
sight-threatening retinopathy on two consecutive 
screening visits was unnecessary and screening 
every three years was most cost-effective. A further 
model using individual risk scores found that 
people at low risk could be safely and effectively 
screened every five years. this has significant 
implications for resource use in the nhS, which 
has recommended a change in routine screening 
interval to every two years for low risk groups.
ReAD MORe (Study 22)
An interesting ongoing programme of research 
in Liverpool aims to further explore the possibility 
of varying the time between retinopathy screening 
for individuals based on their degree of risk. It will 
explore whether it would be safe and acceptable 
to patients if the time between screenings 
was longer for people at lower risk. Based on 
around 18,000 people, it will measure the risk of 
progression to treatment and visual impairment as 
well as using qualitative methods to assess patient 
and professional experience.
ReAD MORe (Study 23)
Particular screening approaches have also been 
explored. One study investigated whether colour 
vision testing could work as a way of detecting and 
monitoring the progress of diabetic retinopathy, 
although it found insufficient evidence to 
recommend it as an effective method. 
ReAD MORe (Study 24)
Another ongoing study in London is exploring 
whether the efficiency of retinopathy screening 
could be improved by automating the first part of 
the retinal image assessment process. this could 
generate savings for the nhS with more effective 
deployment of trained image graders. 
ReAD MORe (Study 25)
A recent Cochrane review looked at the effect 
of blood pressure control on diabetic retinopathy. 
It found some modest effect on preventing eye 
disease for up to four years but no good evidence 
on delaying progression of retinopathy. the 
authors concluded that although reducing blood 
pressure may have overall benefits for people 
with diabetes, current evidence does not justify 
treatment to delay or prevent diabetic  
retinopathy alone.
ReAD MORe (Study 26)
EyEs
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EyEs ON THE pRIzE? 




A new nIhR study will review the evidence 
for the best ways of encouraging attendance at 
retinopathy screening and explore the reasons 
for people not attending. the outputs from this 
project will be used to make recommendations 
on the design of evidence-based and cost-
effective screening interventions in areas or 
population subgroups with low uptake and to 
make recommendations for future research to 
inform UK screening policy.
ReAD MORe (Study 27)
A multicentre study involving over 3000 
patients investigated the best method of 
detecting macular oedema. the study found 
that a fully automated approach identifying 
patterns of surrogate markers was more cost-
effective than current manual methods. the 
study also found that adding optical coherence 
tomography (a form of ultrasound scanning) 
prior to referral resulted in cost savings without 
reducing health benefits. 
ReAD MORe (Study 28)
In terms of treating diabetic macular oedema 
if it is detected, a new study will compare the 
effectiveness and cost-effectiveness of a specific 
laser therapy (Diode Subthreshold Micropulse 
Laser) compared with standard laser treatment 
for adults with the condition. the study aims to 
recruit patients across ten UK hospitals with a 
two year follow-up, and results are expected in 
late 2020.
ReAD MORe (Study 29)
evaluating treatments for diabetic 
retinopathy is important too. If it is detected, 
there are a number of options that depend on 
the nature and extent of the retinopathy. For 
proliferative retinopathy this usually involves 
laser treatment to remove the fragile new blood 
vessels, resulting in reduced risk of the bleeding 
that can lead to blindness. A recent study 
investigated the cost-effectiveness of different 
treatments, including a particular form of laser 
(pan-retinal photocoagulation), for background 
retinopathy at an earlier stage of the disease. 
the study found that evidence for this newer 
approach was not strong enough for it to be 
routinely recommended.
ReAD MORe (Study 30)
EyEs cont.
An important microvascular complication of 
type 2 diabetes is kidney damage, which can 
lead to chronic kidney disease and potentially 
end stage kidney failure. Over one in ten people 
with type 2 diabetes die of kidney disease. One 
of the key challenges is detecting the onset of 
kidney disease and an nIhR study investigated 
the best way of testing for kidney damage. they 
found that once yearly screening with albumin 
to creatinine ratio (a urine test) appeared to 
be the most cost-effective method, and this 
supported nICe guidance to test annually. the 
same study also found benefits of reducing 
kidney damage by using medications that inhibit 
the renin angiotensin aldosterone system in 
people with type 2 diabetes.
ReAD MORe (Study 31)
Recently published information from the 
eMPA-ReG OUtCOMe trial (not nIhR funded) 
has shown that, in patients with type 2 diabetes 
at high cardiovascular risk, empagliflozin was 
associated with slower progression of kidney 
disease (Wanner 2016).
kIDNEys
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WHaT abOuT THE sysTEM? usING ROuTINE 
INFORMaTION TO uNDERsTaND DIabETEs sERvICEs
Information collected by hospitals and GP practices can tell us a lot about how people with type 2 
diabetes use services and what can be improved. two studies used national data collected routinely to 
study associations between different parts of the system. One study looking at those people identified with 
diabetes over five years found that those with better access to primary care whose diabetes was managed 
well in general practice were less likely to have hospital admissions related to diabetes complications. 
Another large population set showed that hospital records did not always identify diabetes-related 
admissions. this means that there could be more hospital admissions than currently estimated for people 
with diabetes. these observational studies can be useful in identifying markers for improvement and 
further work.
ReAD MORe (Studies 34 & 35)
how hAs reseArCh helped deCision-
mAkers?
W
e know that regular checking and 
supporting patients to live well with 
the disease are key components of 
good type 2 diabetes care, but this is 
often hard to do. nIhR research has addressed key 
uncertainties for clinical staff and service leaders 
and has contributed to nICe and SIGn guidelines 
on type 2 diabetes. this includes drug treatments, 
treatment targets and recommendations on the 
optimal screening interval for diabetic retinopathy 
and diabetic kidney disease. 
Other research is helping develop more efficient 
approaches to screening, with use of automation 
and new technologies. A large-scale european study 
(the ADDItIOn trial) has shown that, although early 
intensive management did not reduce risk of deaths 
and cardiovascular events after five years, it did result 
in better diabetes control and potential longer term 
cardiovascular benefits. nIhR has also contributed to 
evidence on comparative effectiveness of medicines 
to control blood sugar levels, adding value to other 
research funded by industry and charities.
type 2 diabetes can also lead to nerve damage, 
which causes particular problems in the legs and 
feet due to neuropathy (nerve damage, which is 
often painful) and risk of ulceration. Again, early 
detection is important and so a study was funded 
to explore the best ways of identifying people at 
risk of developing foot ulcers. they found that 
people at greatest risk had a previous history of 
foot ulceration, inability to feel the pressure from 
a specific sensation-testing instrument, at least one 
absent foot pulse, and longer time after diagnosis. 
ReAD MORe (Study 32)
An interesting new approach to identifying 
the early signs of diabetic neuropathy in limbs is 
being explored. Corneal confocal microscopy is a 
non-invasive eye test which can be delivered in 
community optometry practices alongside routine 
retinal screening. A feasibility study is underway.
ReAD MORe (Study 33)
FEET
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sELF-MaNaGEMENT
pROpORTION OF pEOpLE NEWLy DIaGNOsED 
WITH TypE 2 DIabETEs WHO WERE OFFERED 
THE OppORTuNITy TO aTTEND a sTRuCTuRED 
EDuCaTION COuRsE (2014/15)
pROpORTION OF pEOpLE NEWLy DIaGNOsED 
WITH TypE 2 DIabETEs WHO aTTENDED a 
sTRuCTuRED EDuCaTION COuRsE (2014/15)
76%
5.3%
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p
eople with type 2 diabetes may see their GP 
or another healthcare professional for a short 
appointment once or twice a year – the rest of 
the time they must manage their condition by 
themselves. Supporting people to do this successfully 
is crucial to avoiding complications. Self-management 
may include a number of elements, such as attending 
eduction programmes, seeking psychological support, 
diet and exercise management, and some form of 
blood glucose monitoring. Balancing these complex 
elements is challenging and patients need support to 
develop the right knowledge and skills.
Provision of this support is a clinical and policy 
priority. Current nICe guidance recommends that 
everyone newly diagnosed with type 2 diabetes 
should be offered access to a structured education 
programme, with annual ‘refresher sessions’.  
they should also have ongoing, individualised 
nutritional advice from a qualified healthcare 
professional, in addition to regular support from  
a GP and/or specialist nurse. 
From 2016/17 commissioners in england will be 
expected to report against two key indicators, one 
of which is the number of people with new type 
2 diabetes (diagnosed within the previous year) 
who attend a structured education course. Recent 
data from the national Diabetes Audit suggests 
that in 2014-15, although more than three quarters 
of recently diagnosed patients had been offered 
structured education, only 5.3% had attended  
(hSCIC 2016). A report from Diabetes UK suggests 
that over a third of commissioners are not supporting 
specific courses for people with type 2 diabetes 
(Diabetes UK, 2015).
In the three years since my type 2 diabetes diagnosis I have spent less 
than an hour in total with health care professionals talking about my 
condition.
During the same period I have spent more time thinking about my 
health than in the thirty years previously. My condition impinges on my 
life and thoughts at every turn. Very rarely does a couple of hours go by in 
which I don’t make a decision relevant to managing my diabetes.
Most of these are very small, but cumulatively they take up a great 
deal of my thinking.
robin swindell, london
I was recently diagnosed with type 2 diabetes. Although aware of what 
diabetes was because of the family history, I was a bit lost as to how to 
manage it... I did not know what to expect from the course but it has given 
me a big encouragement to carry on changing my life and determine to live 
a long life with this illness. I have already signed up for a sponsored walk to 
raise money for Diabetes UK.  
person with diabetes attending education programme, leicester
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DIGITIsING DIabETEs? ROLE OF NEW TECHNOLOGy 
TO HELp pEOpLE MaNaGE THEIR DIabETEs
evidence suggests that using computer-based packages to help patients manage blood glucose can 
have a small but positive effect – and mobile phone apps may be even better. So far, the packages tested 
haven’t been shown to affect other outcomes, such as blood pressure or weight – but research is limited 
to date, and not always of good quality. the nIhR has funded new work to develop a computer-based 
management programme for people with type 2 diabetes (due to publish shortly).
ReAD MORe (Study 38)
struCtured eduCAtion
the nIhR has supported research in a number of 
areas to explore the most effective approaches to 
self-management, of which structured education is 
one of the most important. It is usually delivered in 
groups and provides an opportunity for patients to 
learn more about food choices, physical activity, self-
monitoring and medication, and to set personal goals 
and action plans.
In the UK, two programmes are commonly offered 
which meet the national standards: Diabetes education 
and Self-Management for Ongoing and Diagnosed 
(DeSMOnD: one or two half-day sessions, delivered in 
a group of up to 10 patients) and X-PeRt (six shorter 
weekly group sessions and annual follow-up). 
A Diabetes UK-funded evaluation of the DeSMOnD 
programme found that it helped attendees improve 
in some areas, such as weight loss, smoking and 
depression, though no benefit was shown on blood 
glucose. the evidence of sustained health benefits is 
not as strong: improvements were sustained for one 
year, but not for three years, suggesting that follow-
up support and/or refresher sessions are important 
(Davies, 2008; Khunti, 2012).
Patients at high risk of type 2 diabetes 
complications – men, smokers, and those who 
struggle to achieve good glycaemic control – are less 
likely to attend education. Patients report a range 
of barriers including access issues (such as timing 
of sessions or parking); personal preferences (for 
example, some were uncomfortable with the group 
format); or feelings of shame or stigma around their 
diagnosis. But the most commonly reported reason 
for non-attendance in one qualitative study was that 
the healthcare professional had either not mentioned 
education at all, or had not clearly spelt out the 
benefits to the patient.
ReAD MORe (Study 36)
Similarly, early work undertaken to support a 
new study identified a degree of scepticism about 
structured education among some GPs and practice 
nurses, so new research is aiming to understand 
the reasons for this and to develop guidance and 
practical support to help Clinical Commissioning 
Groups embed education in their areas. 
ReAD MORe (Study 37)
An nIhR systematic review of evaluations of 
educational interventions in type 2 diabetes found 
mixed results. Overall, the review indicated that 
programmes that include a range of different 
components are more likely to be successful, 
particularly those delivered by a team. there is a 
strong suggestion that education which is reinforced 
through further contact after the initial session is 
more likely to make a difference. 
ReAD MORe (Study 39)
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motivAting And supporting pAtients
nIhR research has explored some of the 
behaviours, techniques and strategies that may 
improve type 2 diabetes management. For example, 
a review of patients’ views of self-managing type 
2 diabetes found that having a sense of ownership 
of their management was important. this included 
being able to set their own treatment goals and 
having an individualised treatment plan. 
ReAD MORe (Study 40)
these findings are echoed by a review of self-
management interventions for men with long term 
conditions (not just type 2 diabetes), which found 
that tailoring support to individual preferences was 
important and that multicomponent approaches 
(such as combined education, physical activity and 
peer support) improved quality of life.
ReAD MORe (Study 41)
Another study identified the potential of 
psychological training for nurses to improve the 
support they are able to offer to patients around  
self-management, and an ongoing study will explore 
the potential benefit of psychological interventions 
for patients.
ReAD MORe (Studies 42 & 43)
For some people there are particular challenges 
to managing type 2 diabetes. For example, several 
ongoing nIhR projects are exploring how to 
support self-management of type 2 diabetes among 
people with learning disability (or help prevent its 
occurrence in the first place). Part of this study has 
involved exploring ways of identifying people with 
learning disability who are not on GP registers. early 
findings suggest that people with learning disability 
are at greater risk of type 2 diabetes because of 
high prevalence of overweight and obesity and 
that obesity may be a bigger health problem than 
glycaemic control. 
ReAD MORe (Study 44)
monitoring blood gluCose
Self-monitoring of blood glucose – usually done 
with a portable glucose meter – is not recommended 
by nICe for the majority of people with type 2 
diabetes who are not taking insulin, but an nIhR 
review has explored whether it should be considered 
in certain circumstances. Results were mixed, but 
overall self-monitoring of blood glucose was linked 
to small decreases in hbA1c – though only when 
accompanied by education or some form of feedback 
to patients about their results. Simply asking patients 
to monitor without education or support did not lead 
to reductions in blood glucose. Improvements were 
unlikely to be clinically significant, and therefore 
self-monitoring for this group would probably not be 
cost-effective. the review also found self-monitoring 
was not suitable for all. While some patients found 
it empowering and reassuring, others experienced 
feelings of guilt and depression.
ReAD MORe (Study 45)
GROup CLINICs: COuLD LEaRNING FROM THE us 
HELp IMpROvE sERvICEs HERE?
At the moment, apart from structured education, most diabetes care is provided at individual GP or 
nurse appointments. But in the US, there is more widespread use of ‘group clinics’ – a form of specialist-
led care that is delivered in groups, and may include aspects of clinical management as well as education 
and support. this could offer patients better access to specialists and the benefits of peer support, whilst 
holding the potential for cost savings too. A review of mainly US evidence found group clinics were 
associated with improved blood glucose and blood pressure, and in some cases improved quality of life. 
there is a need for clearer evidence on cost, and to explore how this promising approach could translate 
to the UK. 
ReAD MORe (Study 46)
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how hAs reseArCh helped deCision-
mAkers?
W
e know that the role of the patient 
is key to effective management 
of type 2 diabetes, but 
for many people this is 
challenging. nIhR research has included  
a strong patient focus, seeking to 
understand the motivations, preferences 
and perspectives of patients in order to  
improve care. For instance, nIhR research 
has explored why so many patients do not 
attend structured education, finding that the 
role of the health professional in explaining and 
encouraging attendance is important. Other studies 
have shown how patients value individualised care 
with tailored goals. Research into self-monitoring 
of blood glucose for patients with type 2 diabetes 
looked not only at its effectiveness, but also how 
patients felt about it – which showed that for some  
it was associated with negative feelings. this research 
informed nICe guidelines on self-monitoring. 
nIhR research has also explored the effectiveness 
of key components of self-management, particularly 
education. this found that multi-component 
packages, delivered by a team and with follow-up  
contact afterwards, were most effective. Future 
research will explore the role of psychological 
therapies in helping patients self-manage. nIhR 
research has informed nICe and SIGn guidelines  
on the management (including self-management)  
of diabetes.
buILDING bLOCks? GROWING THE EvIDENCE basE 
ON DIET aND ExERCIsE
nIhR Biomedical Research Units (BRU) are based in the nhS with a role to drive innovation in healthcare 
and ensure research advances are converted into benefits for patients. Several BRUs are investigating the 
effectiveness of different dietary and activity schedules for people with type 2 diabetes. new findings 
include:
 » encouraging people with type 2 diabetes to break up sedentary time with even short bouts of activity 
could lead to improvements in metabolic health. Similarly, breaking up prolonged sitting seems to have 
a positive effect on blood glucose for women at risk of developing type 2 diabetes 
ReAD MORe (Studies 47 & 48)
 » Short bouts of very vigorous exercise show potential for being more effective than moderate exercise in 
managing blood glucose levels. this is now being explored further in the South Asian population
ReAD MORe (Study 49)
 » An intensive dietary intervention with monthly dietary consultations showed benefits in glycaemic 
control 
ReAD MORe (Study 50)
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why reseArCh mAtters to 
Commissioners
T
his review has highlighted some of the 
important programmes and projects on 
diabetes prevention, management and 
care funded by the nIhR. these include 
population-based studies, trials comparing 
effectiveness of different treatments, and mixed 
methods research considering how to tailor services 
to particular needs. nIhR funding programmes decide 
which studies to fund, using panels of clinicians, 
managers, patients and researchers. they help to 
prioritise research and to identify the most pressing 
problems where evidence is needed. 
As well as these national needs-led programmes, 
the nIhR also supports thirteen local Collaborations 
for Leadership in Applied health Research and Care 
(CLAhRCs) which encourage partnership between 
universities and service organisations. each of the 
thirteen CLAhRCs in england have active programmes 
of work around diabetes and other long-term 
conditions. Only some of these diabetes projects are 
featured in this report; information on all CLAhRC  
funded research is available at www.clahrcpp.co.uk. 
the nIhR working as a whole system can test 
interventions at scale and pull through research of 
different kinds. An example of this is a small study in 
one CLAhRC of a promising intervention to increase 
physical activity which is now being tested in a multi-
centre trial funded by a national nIhR programme 
(see Study 3).
there is also infrastructure funding for more basic 
research and centres of excellence, some particularly 
relevant to diabetes. the nIhR provides some core 
and project-based funding for Cochrane review 
groups, which synthesised published evidence such as 
the review of blood pressure management to prevent 
retinopathy cited in this report (see Study 26).  
DEvELOpING a sysTEM 
TO suppORT DIabETEs 
REsEaRCH
In an environment where the funding available for health services is 
being squeezed, it is increasingly important that the decisions we make 
around the commissioning and de-commissioning of health services 
are informed by robust evidence. This can be extended beyond specific 
treatments and interventions to how the system organises itself in 
response to wider health system reform.
Research offers an important independent perspective to what may 
seem like intractable system-wide issues to commissioners. It can support 
commissioners in both evaluating existing services and commissioning  
new services.” 
bristol CCg transformation team
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WHaT’s NExT? NEW appROaCHEs TO NON-INvasIvE 
bLOOD GLuCOsE MONITORING
Monitoring blood glucose levels is key to successful self-management. At present this is done through 
fingerprick tests which can be inconvenient and painful. new approaches are now being developed for 
non-invasive blood glucose monitoring by tests on skin, tear fluid, saliva and breath. A helpful review 
has been published of these new and emerging technologies by the nIhR horizon Scanning Research & 
Intelligence Centre. www.hsric.nihr.ac.uk/topics/review-new-and-emerging-non-invasive-glucose-monitoring-
technologies/ these have not yet been fully evaluated and none are currently in routine use. new research 
will be needed to identify the cost-effectiveness of different approaches – watch this space.
Diabetes is an important disease and many advances 
have been made through research supported by 
research councils, charities, industry and independent 
organisations. the nIhR is one player in this landscape. 
through its networks, units, programmes and grants 
it supports research with a particular focus on the 
needs of nhS decision-makers. these include those 
planning, commissioning, delivering and using services. 
evidence is needed at a population level to inform 
better services and at an individual level to enable 
clinicians and patients to make better decisions 
about treatments and approaches to living well with 
diabetes. nIhR research complements other research 
activity and aims to build research capacity and 
infrastructure to support diabetes research which will 
address key uncertainties in the future.
See www.cochranelibrary.com for details of all the 
reviews undertaken through Cochrane.
the nIhR has also helped support research in other 
ways. this includes support for local clinical research 
networks and a national specialty network focused 
on diabetes (www.crn.nihr.ac.uk). these provide 
valuable help from research nurses collecting data to 
help in recruiting patients to trials and other studies 
in hospitals, practices and the community. 
the nIhR also enables individual researchers through 
fellowships and training posts with a focus on diabetes 
(www.nihr.ac.uk/funding/training-programmes.htm).
there are other kinds of research supported by 
nIhR which are less visible. these include technology 
Assessment Reports which provide robust evaluation 
of treatments, including evidence submitted by drug 
manufacturers. this helps to inform decisions about 
therapies by nICe. A recent US Preventive Services 
taskforce review on prevention of type 2 diabetes 
cited a technology Assessment Report as the most 
comprehensive previous review.
Looking ahead, the nIhR also tries to identify new  
and emerging technologies of the future through  
its horizon Scanning Centre.
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appENDICEs
summAries of feAtured nihr studies 
these studies were funded by the nIhR through a 
wide range of funding programmes, research centres 
and collaborations, workstreams and individual 
research fellowships. they include a variety of studies, 
from large, long-term primary research projects to 
smaller grants and reviews of published research. to 
find out more about these programmes and other 
funded work, visit www.nihr.ac.uk.
STUDY 1 (PUBlISHED) 
Non-pharmacological interventions to reduce the risk of diabetes 
in people with impaired glucose regulation: a systematic review 
and economic evaluation
Published 2012, Gillett
the aim of this study was to review the clinical and cost-
effectiveness of non-pharmacological interventions, such as diet 
and physical activity, aimed at preventing type 2 diabetes in people 
with intermediate hyperglycaemia. nine randomised trials with a 
total of 5875 participants were identified that compared lifestyle 
interventions (mainly dietary and physical activity advice) with 
standard care. the primary outcome was progression to diabetes. 
In most trials, progression was reduced – in some cases, by more 
than half. the greatest effects were seen in participants who 
adhered best to the lifestyle changes. the most cost-effective 
option of those studied appeared to be lifestyle change followed 
after a year with medication for those finding it difficult to make 
the changes.
health technol Assess 2012 doi: 10.3310/hta16330
STUDY 2 (PUBlISHED) 
A community based primary prevention programme for Type 2 
Diabetes integrating identification, lifestyle intervention and 
community services for prevention. 
Published 2016, Davies 
this was a cluster randomised trial involving over 700 patients 
from 44 practices over four years. Patients at risk of diabetes 
were identified by general practitioners using a predictive risk 
tool developed and validated by the team. those at risk could 
be allocated (by practice) either to a structured education 
programme, Let’s Prevent Diabetes (LP) or a control. LP is an 
initial 6 hour group lifestyle modification programme with three 
hour refresher sessions at years one and two and was developed 
by the team based on an effective initiative for people with 
established diabetes (DeSMOnD). Participants were followed up 
at yearly intervals over three years from the start. the study found 
that there was a reduced risk of developing diabetes in those 
who received the education programme, but this did not reach 
statistical significance. however, participants did demonstrate 
improvements in blood glucose, cholesterol and activity levels, and 
analysis suggested that the programme is likely to be cost-effective.
Preventive Medicine 2016 doi:10.1016/j.ypmed.2015.12.012 
STUDY 3 (oNGoING) 
The PRomotion of Physical activity through structured Education 
with differing levels of ongoing Support for those with 
prediabetes (PRoPElS): randomised controlled trial in a diverse 
multi-ethnic community. 
Due to publish 2020
this study builds on earlier nIhR work to test different versions of 
an intervention to increase physical activity in a diverse population 
at risk of diabetes. the aim is to recruit over 1300 people at risk 
of diabetes from two regions in england including ethnically 
diverse populations. Participants will receive one of the following: 
information in a leaflet (control); a structured half-day education 
intervention, tailored where needed to particular ethnic groups; 
or the education session plus monthly support through email and 
mobile phone. Physical activity, measured by an accelerometer 
will be the primary outcome, together with blood glucose levels 
and other markers.  the study will test different levels of support, 
including intensive telephone follow-on coaching by trained 
educators and text feedback and goal setting support. A four 
year follow-up will determine whether the programme leads 
to sustained increases in physical activity and a reduced risk of 
diabetes, and whether the intervention is cost-effective.
http://www.nets.nihr.ac.uk/projects/hta/0916202
STUDY 4 (PUBlISHED)
Association between change in daily ambulatory activity and 
cardiovascular events in people with impaired glucose tolerance 
(NAVIGAToR trial): a cohort analysis
Published 2014, Yates
this international study, supported by the nIhR Leicester-
Loughborough Diet, Lifestyle and Physical Activity Biomedical 
Research Unit, analysed data from a large international cohort of 
9306 individuals with impaired glucose tolerance (denoting a high 
risk of type 2 diabetes) and found that changing activity levels by 
2000 steps/day over a 12 month period led to an 8% reduction in 
the risk of cardiovascular disease or cardiovascular death over a 5 
year period. 2000 steps/day equates to just 20 minutes of walking. 
During 45,211 person-years follow-up, 531 cardiovascular events 
occurred. Baseline ambulatory activity (hazard ratio [hR] per 2000 
steps per day 0·90, 95% CI 0·84-0·96) and change in ambulatory 
activity (0·92, 0·86-0·99) were inversely associated with the risk 
of a cardiovascular event. this study was the first to quantify the 
importance of making simple and attainable changes to walking 
activity to the future cardiovascular health in those with a high risk 
of type 2 diabetes.
Lancet doi: 10.1016/S0140-6736(13)62061-9
STUDY 5A (PUBlISHED)
A motivational peer support program for type 2 diabetes 
prevention delivered by people with type 2 diabetes: the UEA-IfG 
feasibility study. 
Published 2012, Murray
this study investigated the feasibility of developing a peer 
support program for people at high risk of type 2 diabetes. It 
investigated whether lay members of the public who had existing 
type 2 diabetes could become ‘type 2 trainers’ and be trained to 
offer phone support to people who are at risk of developing the 
condition. It also considered the costs of doing so. the training 
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involved seven sessions covering issues such as exercise, healthy 
eating, motivations and barriers. the researchers successfully 
recruited and trained 25 lay people to be type 2 trainers. there was 
a high degree of retention of type 2 trainers (89% still involved 
at 20 months). the study therefore found that recruiting and 
training lay volunteers with diabetes to support people at risk of 
developing diabetes was a feasible strategy and probably cost 
effective compared to employing salaried health care professionals. 
Diabetes educ 2012  doi: 10.1177/0145721712440332.
STUDY 5B (PUBlISHED)
A qualitative assessment of using lay trainers with type 2  
diabetes in an intervention programme for people at risk of  
type 2 diabetes. 
Published 2011, Sampson
this qualitative study explored the acceptability, perceived 
effectiveness and sustainability of using lay trainers with type 2 
diabetes as part of a dietary and exercise intervention programme 
to reduce incidence of diabetes among people at risk. the study 
used a series of focus groups involving lay trainers, people who had 
received their support and health professionals working with the 
lay trainers. Lay trainers were seen as a complementary method to 
motivate individuals to reduce their risks of diabetes. Advantages 
included lay trainers’ ability to communicate ways of coping with 
type 2 diabetes in a way that people could understand. 
health education Journal 2012 doi: 10.1177/0017896911430562 
STUDY 5C (oNGoING)
Delivering a Realistic Diabetes Prevention Programme in a UK 
Community: The Norfolk Diabetes Prevention Study (Norfolk DPS) 
– ongoing 
Due to publish 2018
Building on these two studies, a programme grant is now 
underway as part of a larger diabetes prevention evaluation. 
the mentoring element will be tested in a clinical trial. As a new 
element, the study will also measure any improvement in diabetes 
control for the mentors themselves, as well as those at risk of 
diabetes receiving the education and support. 
http://www.norfolkdiabetespreventionstudy.nhs.uk/ 
STUDY 6 (PUBlISHED)
ffIT football fans in Training scheme
Published 2015, Wyke
An nIhR-funded trial, evaluating the effectiveness of a 
programme to help football fans lose weight, feel better and live 
a healthier lifestyle, was delivered via the Scottish Professional 
Football League Football (SPFL) trust. the Football Fans in 
training (FFIt) scheme is a free, 12-week programme which ran 
at 13 SPFL clubs. Men attended 12 weekly sessions at their local 
club to learn useful skills and techniques to help them improve 
their physical activity and diet. A team of researchers funded by 
the PhR Programme developed the evidence-based programme 
and evaluated its effectiveness. It was one of the world’s first 
randomised controlled trials of a health programme delivered 
through professional sports clubs. It proved extremely popular, 
recruiting around 750 men to take part. the study found that men 
who participated in the FFIt scheme lost more than nine times as 
much weight as those who did not take part in the programme. 
Participants also benefited from reduced waist size, less body fat 
and lower blood pressure.
Public health Res  doi: 10.3310/phr03020
STUDY 7 (PUBlISHED)
Costs and outcomes of increasing access to bariatric surgery 
for obesity: Cohort study and cost-effectiveness analysis using 
electronic health records
this study carried out an analysis of electronic health records in 
order to explore the impact of increasing access to bariatric surgery 
for obesity. the specific outputs below describe the findings;  
an overall account of the work can be found in the nIhR  
Journals Library:
http://www.journalslibrary.nihr.ac.uk/hsdr/volume-4/issue-17#
a) Incidence of type 2 diabetes after bariatric surgery: 
population-based matched cohort study. 
Published 2014, Booth
this research aimed to consider the costs and outcomes 
of increasing access to bariatric surgery. this large-scale 
population study used routine practice data (from the Clinical 
Practice Research Datalink) and modelling techniques to 
compare outcomes, including progression to diabetes, in 
over 2000 obese people undergoing bariatric surgery with 
matched controls. the team was able to track long-term 
health outcomes. the researchers followed their progress for 
an average of about three years (maximum of seven years) to 
investigate the relationship between having bariatric surgery 
and risk of developing type 2 diabetes. they found that only 
4% of people who had received bariatric surgery developed 
diabetes compared with 16% of matched controls. the 
researchers concluded that bariatric surgery is associated with 
reduced risk of developing clinical diabetes in people with 
obesity for up to seven years after the procedure.
Incidence of type 2 diabetes after bariatric surgery:population-
based matched cohort study. doi: 10.1016/S2213-8587(14)70214-1
b) Probability of an obese Person Attaining Normal Body 
Weight: Cohort Study Using Electronic Health Records. 
Published 2015, Fildes
In a related study, drawing on a larger population (from the 
same data source) over a longer time, the investigators looked 
at the impact of community obesity programmes other than 
surgery. they analysed data for 76,704 obese men and 99,791 
obese women for up to nine years. they found that the chances 
of an obese man with BMI in the range 30-34.9 attaining 
normal weight in any given year was 1 in 210 and this figure 
was 1 in 124 for women. the chances were smaller for higher 
levels of BMI (for example the annual probability of a man with 
BMI 40-44.9 achieving normal BMI was 1 in 1290). they also 
looked at the probability of people achieving a 5% reduction 
in body weight (used because it is a widely recommended 
target for weight loss) and found that, for people with BMI 30-
34.9, they chance was 1 in 12 for men and 1 in 10 for women. 
however, they also found that the majority of people losing 
5% of their weight went on to regain it in the following 2-5 
years. In the light of these findings, the authors suggest that 
community-based weight management programmes for obesity 
may have trouble succeeding. 
Am J Public health 2015 doi: 10.2105/AJPh.2015.302773.
c) Effect of Contemporary Bariatric Surgical Procedures on  
Type 2 Diabetes Remission. A Population-Based Matched 
Cohort Study. 
Published 2016, Gulliford
In a further related study, 826 obese patients with type 2 
diabetes were followed up after bariatric surgery (gastric 
banding, gastric bypass and sleeve gastrectomy) and compared 
with a control group. About 30% were found to be in 
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remission of their diabetes in the second year of follow up (this 
varied slightly by type of procedure). this remission was found 
to persist up to the end of the six year follow up period. 
Obesity Surgery doi: 10.1007/s11695-016-2103-6
STUDY 8 (oNGoING)
East Midlands ClAHRC Radiate project
People from black and minority ethnic (BMe) groups are 
at a disproportionate risk of developing type 2 diabetes and 
experiencing associated complications. Prevention strategies 
should be aware of these groups’ experiences, knowledge and 
understanding about their risk of developing type 2 diabetes. 
the aim of this project is to explore these issues with diverse BMe 
groups with view to informing a social marketing campaign to 
raise awareness of diabetes risk and prevention. 
A scoping literature review identified existing evidence of 
contributory factors to the higher prevalence of type 2 diabetes 
in BMe communities. Seven focus groups were then convened 
which discussed levels of awareness of diabetes and the cultural 
influences on lifestyle choices and behaviours. Indicative findings 
strongly suggest that a ‘one size fits all’ social marketing campaign 
or intervention would not work due to diverse cultural beliefs and 
traditions. this study is demonstrating the complex inter-related 
factors which can influence development of type 2 diabetes both 
across and within BMe communities and how, by working in 
partnership with community members, strategies can be developed 
to support healthier lifestyle choices. this work will illustrate an 
efficient, cost effective methodology which would be applicable  
in all communities, for multiple conditions and situations resulting 





NIHR ClAHRC Greater Manchester: Evaluating lifestyle 
interventions
Due to publish 2017
As part of the national Diabetes Prevention Programme, Public 
health england has commissioned seven demonstrator sites to 
explore the local implementation of lifestyle interventions to 
prevent diabetes among people at risk of developing the disease. 
the Salford demonstrator site includes a telephone support service 
(Care Call), an exercise programme and a new community-based 
service to improve the identification and referral of people at risk 
of diabetes from hard to reach groups. this builds on previous 
research which included an uncontrolled before-after study 
showing promising results for health coaching, and an ongoing 
trial looking at the role of web-based coaching. they will conduct 
a mixed-methods evaluation, using qualitative interviews with 
professionals, observation analysis and quantitative process-related 
data collection, focussing on three objectives:
1. Identify what role a community referral service can play in 
supporting people at risk of diabetes to access and use lifestyle 
support services 
2. Identify what role an enhanced GP referral service can play in 
supporting people at risk of diabetes to access and use lifestyle 
support services 
3. Describe the Care Call service model, present the evidence 
that underlies it, and look at the extent to which Salford’s 
telephone-based intervention approach aligns with the service 




Pilot interventions with children from ethnic minority groups 
the aims of this project are (1) to develop and pilot interventions 
based on changes in diet and behaviour to prevent insulin 
resistance in children from ethnic groups at high risk for type 2 
diabetes and (2) to develop and pilot interventions to improve the 
identification of overweight-obesity in children, particularly those 




NIHR ClAHRC North Thames: A participatory female health-
volunteer led intervention to promote healthy nutrition in children 
of Bangladeshi origin in East london. 
Due to publish 2019
neOn (nurture early for Optimal nutrition) is a partnership 
between the department of Population, Policy and Practice, 
University College London, Barts and the London nhS trust and the 
Bangladeshi community of tower hamlets. the project explores 
the socio-ecological influences of feeding practices of infants 
in the Bangladeshi community. tower hamlets experiences the 
highest prevalence of low birth weight babies born at term, and 
approximately one third of residents are of Bangladeshi origin. 
Prevalence of obesity in British Bangladeshi children aged 4-5 
years is 12.5%, growing to 23.7% by age 10-11 years, and the 
South Asian community are 2-4 times more likely to develop type 2 
diabetes in adulthood. the project involves literature reviews, focus 
groups, creative initiatives and active engagement with both the 
community and health professionals. Collated information will be 
used to inform the design and implementation of a participatory 





NIHR ClAHRC North Thames: Co-designing community-based 
diabetes services responsive to the needs of children and  
young people. 
Due to publish 2017
this project was designed to inform and influence the re-design 
of children and young people’s diabetic services and improve peer 
education. the focus of the project was initially on newham, and 
has widened to other parts of east and north London. the project 
is half way through its 30 month programme, and has already 
recruited fourteen young people living with type 1 or 2 diabetes 
or who care for a relative with diabetes. the young people joined 
the project as cultural advisors, co-inquirers, diabetes champions 
and Youth Commissioners. A mixed methodology and participatory 
approach has been adopted, and activities include a literature 
review, qualitative interviews, and community workshops, all of 
which are to ensure active engagement with young people and 
commissioners. to date, outputs include Service Commissioning 
Guidance for Children and Young People Diabetes Services (2016-
17) and newham CCG Youth Diabetes Project Business Case (2016-
17). this project has also led to work on designing educational 
materials to encourage Youth Forums in the nhS.
http://www.clahrc-norththames.nihr.ac.uk/co-designing-young-
peoples-diabetic-services/
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STUDY 13 (PUBlISHED)
Anglo-Danish-Dutch study of Intensive Treatment of people with 
Newly diagnosed diabetes in primary care (ADDITIoN) - effects on 
cardiovascular events at five years. 
this study explored whether earlier detection and intensive 
treatment of diabetes are worthwhile. It has produced a range 
of outputs on different aspects of diabetes screening and 
management, which are described below.
SCReenInG:
a) Screening for type 2 diabetes and population mortality 
over 10 years (ADDITIoN-Cambridge): a cluster-randomised 
controlled trial 
Published 2012, Simmons; 2011, van den Donk
this study was a cluster randomised trial conducted in 33 GP 
surgeries in eastern england in which practices were randomised 
to stepwise screening for undetected type 2 diabetes (27 
practices) using random capillary blood glucose and hbA1c 
or fasting capillary blood glucose followed by an oral glucose 
tolerance test to confirm if positive. this was compared with 
no screening in 5 practices and the main outcome of interest 
was all-cause mortality over ten years (with secondary analyses 
including deaths from cardiovascular disease, cancers, other 
causes and diabetes-related death). they found that all-cause 
mortality was not reduced by undertaking this screening and 
concluded that screening for type 2 diabetes in patients at 
increased risk was not associated with a reduction in all-cause, 
cardiovascular, or diabetes-related mortality within 10 years.
Lancet 2012 doi:10.1016/S0140-6736(12)61422-6.
IntenSIve tReAtMent:
b) Cardiovascular outcomes in the ADDITIoN-Europe study: a 
five-year cluster-randomised controlled trial of multifactorial 
therapy in individuals with screen-detected type 2 diabetes 
Published 2011, Griffin
this study was a cluster randomised trial in 343 GP surgeries 
in Denmark, the netherlands and the UK that aimed to 
investigate whether early intensive management of people 
with type 2 diabetes reduced the occurrence of cardiovascular 
events (myocardial infarction and stroke) and death. this study 
was conducted in people whose diabetes was detected early 
by screening. the intensive treatment consisted of structured 
education, aspirin 75mg daily (unless contra-indicated) and 
individualised, algorithm-driven treatment to optimise blood 
pressure, lipid and blood glucose control. this included blood 
pressure (BP) treatment for people with BP over 120/80mmhg 
(with angiotensin converting enzyme inhibitors) and statin 
for anyone with cholesterol of 3.5mmol/L or higher. this was 
compared with standard diabetes care. the incidence of new 
cardiovascular events was slightly lower in the intervention 
group (7.2% compared with 8.5% in the control group) but the 
difference was not statistically significant. 
Lancet 2011 doi:10.1016/S0140-6736(11)60698-3
MODeLLInG eFFeCtIveneSS AnD COSt eFFeCtIveneSS:
c) Does early intensive multifactorial therapy reduce 
modelled cardiovascular risk in individuals with screen-
detected diabetes? Results from the ADDITIoN-Europe cluster 
randomised trial.
Published 2014, Black 
this component of the ADDItIOn study used modelling to 
estimate the 10 year cardiovascular risk in 2101 people who 
had been randomised to receive intensive therapy compared to 
usual care. the study found that the 10 year modelled risk was 
lower in the intensive treatment group.
Diabetic Medicine 2014 doi: 10.1111/dme.12410
d) Cost effectiveness of early intensive multifactorial treatment 
for individuals with screen-detected type 2 diabetes: analysis 
of the ADDITIoN-UK cluster randomised controlled trial.
Published 2015, Tao
A further study explored the cost effectiveness of the 
intensive treatment offered in the ADDItIOn study in the 
UK study centres (69 GP surgeries) over five years. this was 
using the primary composite outcome of cardiovascular 
events or death. the researchers calculated short term cost 
effectiveness and modelled long-term cost-effectiveness using 
Quality Adjusted Life Years (QALYs). even though there were 
some differences in control of blood sugar, blood pressure 
and cholesterol (favouring the intensive treatment), they 
found no statistically significant difference in short-term 
cost-effectiveness between intervention and control groups. 
From their long-term modelling they concluded that, while 
cost-effectiveness improved over time, it was still higher than 
commonly accepted thresholds after 20 or 30 years.
Diabetic Medicine 2015 doi: 10.1111/dme/12711
MICROvASCULAR COMPLICAtIOnS:
e) Effect of early multifactorial therapy compared to routine 
care on microvascular outcomes at 5 years in people with 
screen-detected diabetes: the ADDITIoN-Europe study. 
Published 2014, Sandbaek
this aspect of the ADDItIOn study explored whether 
the intensive multifactorial therapy had any impact on 
microvascular outcomes in 343 practices in the UK, Denmark 
and the netherlands after 5 years. the main outcomes 
of interest were albuminuria (to reflect kidney disease), 
retinopathy and neuropathy. the authors concluded that there 
were no differences in the frequency of these complications 
between the intervention and control groups. Albuminuria 
was present in 23% in the intervention group and 24% in the 
routine care group, retinopathy was present in 10 and 12% 
respectively and neuropathy in 5 and 6%. these differences 
were not statistically significant and they concluded that the 
intervention was not effective in reducing these outcomes at 5 
years in people with screen-detected diabetes.
Diabetes Care2014 doi.org/10.2337/dc13-1544
MODeLLInG SCReenInG:
f) A comparison of cost per case detected of screening 
strategies for Type 2 diabetes and impaired glucose regulation.
Published 2012, Khunti
the aim of this study was to assess the cost of different 
screening strategies for type 2 diabetes, both alone and in 
combination with impaired glucose regulation. Data was used 
from the ADDItIOn-Leicester study to model 212 different 
screening strategies; including blood tests, a computer practice 
data score and a risk score, and cost per new case identified 
were estimated. Results showed the estimated costs per case 
identified for the 18 most sensitive strategies varied from £457 
to £1639 for type 2 diabetes and £148 to £913 for both type 
2 diabetes and impaired glucose regulation combined. the 
study concluded screening a population using a non-invasive 
risk stratification tool followed by a screening blood test was 
the most cost-effective method of screening for diabetes and 
abnormal glucose tolerance.
Diabetes Research and Clinical Practice. doi: 10.1016/j.
diabres.2012.03.009.
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STUDY 14 (PUBlISHED)
Screening for type 2 diabetes
Published 2013, Waugh
the aim of this review was to provide an update for the UK 
national Screening Committee (nSC) on screening for type 2 
diabetes (from a previous review in 2007). It concluded that 
screening for type 2 diabetes does not meet the nSC criteria. For 
example Criterion 12, on optimisation of existing management, 
was not met, and Criterion 13 requires evidence from high-quality 
randomised controlled trials that screening is beneficial. this 
has not been met - the ely trial of screening showed no benefit. 
the main factor identified was a lack of cardiovascular benefit 
demonstrated in the two trials published since the previous review. 
the review also concluded that no perfect screening test exists – 
hbA1c lacks sensitivity and would miss people with diabetes, and 
although the glucose tolerance test is more sensitive it would have 
lower uptake.
health technol Assess 2013: 10.3310/hta17350 
STUDY 15 (PUBlISHED)
The cost-effectiveness of testing strategies for type 2 diabetes 
Published 2015, Gillett
this study aimed to compare the cost-effectiveness of screening 
for type 2 diabetes using haemoglobin A1c (hbA1c) versus 
fasting plasma glucose (FPG). It also looked at the use of a 
random capillary glucose (RCG) test versus a non-invasive risk 
score to prioritise individuals who should undertake a hbA1c or 
FPG test. the population of interest was people aged 40-74 (i.e. 
those eligible for an nhS health check) in the Leicester ethnic 
Atherosclerosis and Diabetes Risk (LeADeR) study, in order to 
analyse prevalence and screening outcomes for a multi-ethnic 
population. the results suggested that screening using a hbA1c 
test is more cost-effective than using FPG. however, in some places, 
diabetes prevalence and high diabetes risk may be higher for 
FPG relative to hbA1c than in the LeADeR cohort. In such cases, 
whether or not it still holds that hbA1c is likely to be more cost-
effective than FPG depends on the relative uptake rates for hbA1c 
and FPG. Use of the risk score appears to be more cost-effective 
than a RCG test for pre-screening.
health technol Assess 2015 doi:  10.3310/hta19330
STUDY 16 (PUBlISHED)
Assessment of response rates and yields for Two opportunistic 
Tools for Early detection of Non-diabetic hyperglycaemia and 
Diabetes (ATTEND). A randomised controlled trial and cost-
effectiveness analysis
Published 2016, Khunti
the aim of this study was to assess the opportunistic use in 
primary care of a computer risk score versus a self-assessment risk 
score for type 2 diabetes. this was a randomised controlled trial 
carried out in 11 primary care practices in the UK. 577 patients 
aged 40-75 years with no current diagnosis of type 2 diabetes were 
recruited to a computer based risk score, the Leicester Practice 
Computer Risk Score (LPCRS), or a patient self-assessment score, the 
Leicester Self-Assessment Score (LSAS).the rate of self-referral blood 
tests was significantly higher for the LPCRS compared to the LSAS, 
118.98 (95% CI: 102.85, 137.64) per 1000 high-risk patient years 
of follow-up compared to 92.14 (95% CI: 78.25, 108.49), p=0.022. 
Combined rate of diagnosis of type 2 diabetes and those at risk 
of developing the disease (i.e. impaired glucose tolerance (IGt) or 
impaired fasting glucose (IFG) was similar between the two arms, 
15.12 (95% CI: 9.11, 25.08) per 1000 high-risk patient years for LPCRS 
compared to 14.72 (95% CI: 9.59, 22.57) for the LSAS, p=0.699. For 
the base case scenario the cost per new case of type 2 diabetes 
diagnosed was lower for the LPCRS compared to the LSAS, £168 
(95% Credible Interval (CrI): 76, 364), and £352 (95% CrI: 109, 1,148), 
respectively. In conclusion compared to a self-assessment risk score, a 
computer based risk score resulted in greater attendance to an initial 
blood test and is potentially more cost-effective. 
Diabetes Research and Clinical Practice doi:10.1016/j.
diabres.2016.04.054
STUDY 17 (oNGoING/INTERIM fINDINGS PUBlISHED)
A clinical and economic evaluation of screening and diagnostic 
tests to identify and treat women with gestational diabetes: 
association between maternal risk factors, glucose levels, and 
adverse outcomes.
Interim findings published 2015, Farrar
Full findings due to publish 2016
this systematic review will identify all published studies that have 
compared strategies and tests to identify gestational diabetes or 
treat women with gestational diabetes or collected information 
on the associated costs of identifying or treating gestational 
diabetes. It will combine published evidence with population data 
from 12,000 women who took part in the Born in Bradford study 
who had an oral glucose tolerance test when they were 24 to 
28 weeks pregnant. they plan to use modelling techniques and 
other approaches to find out what is the most cost- and clinically-
effective method of identifying women with gestational diabetes 
and which is the most accurate, safe and cost- and clinically-
effective way of treating women to improve outcomes. Interim 
findings from one part of the study – using the Born in Bradford 
cohort data – have been published (Farrar 2015). the findings 
indicate that, as in white British women, women of south Asian 
origin have graded linear associations of fasting and 2 h post-load 
glucose with adverse perinatal outcomes such as very large babies. 
the data suggest lower thresholds for diagnosing gestational 
diabetes in south Asian women than white european women. 
http://www.nets.nihr.ac.uk/projects/hta/119902 
STUDY 18 (oNGoING)
Development of a structured screening and lifestyle intervention 
for prevention of Type 2 Diabetes Mellitus in a population with 
learning Disabilities
Due to publish 2017
this programme of research developed and tested a structured 
screening programme for diabetes in people with learning 
disabilities and developed and piloted a tailored lifestyle 
intervention to reduce risk. People with learning difficulties tend 
to have poorer health status and are more likely to be overweight 
and inactive, and therefore may have a higher risk of developing 
diabetes. Overall the screening part of this programme of work 
found low levels of undiagnosed type 2 diabetes and non-diabetic 
hyperglycaemia (nDh). the investigators also want to find out the 
best way to give people with learning disabilities some education 
around healthy lifestyles (for example, eating and exercise) to help 
with prevention of diabetes and cardiovascular disease. therefore, 
the investigators also aim to develop a lifestyle education 
programme that is suitable for use in this population and test 
whether it is feasible and acceptable.
http://www.nihr.ac.uk/funding/fundingdetails.htm?postid=2236
STUDY 19 (oNGoING)
Diabetes Intervention for Agenda Trial (DIAT)
Due to publish 2016
People with diabetes need to be actively involved in managing 
their condition. they receive advice and support from health 
professionals but these appointments may be infrequent, and it 
may be difficult for a patient to bring up all the issues they would 
like to discuss. this study developed an intervention to help patients 
make the most of their appointments, by first seeing a healthcare 
assistant who guided them through a questionnaire, identifying the 
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most important issues they wished to discuss. the team have piloted 
this approach, to see if it is feasible and acceptable to patients. 
Preliminary findings suggest that the intervention ‘magnified’ the 
existing dynamic in the doctor-patient relationship, whether positive 




Clinical effectiveness of a patient decision aid to improve decision 
quality and glycaemic control in people with diabetes making 
treatment choices: a cluster randomised controlled trial (PANDAs) 
in general practice
Published 2012, Mathers
Patient decision aids provide evidence-based information about 
treatment options, and thus help patients clarify their goals 
and preferences and make informed decisions about treatment. 
this study tested the use of a decision aid in 49 GP practices, 
randomly allocated to use the decision aid or to continue with 
treatment as usual. In practices that used the decision aid, patients 
demonstrated a better understanding of the implications of some 
treatment options, and more realistic expectations of the impact of 
treatments. these patients had a slightly greater improvement in 
glycaemic control, but this was not statistically significant.
BMJ Open 2012, doi: 10.1136/bmjopen-2012-001469
STUDY 21 (PUBlISHED)
Newer agents for blood glucose control in type 2 diabetes: 
systematic review and economic evaluation. 
Published 2010, Waugh
this study explored whether new agents (exenatide, the 
gliptins – and the ‘not so new’ detemir) were clinically and cost 
effective compared to existing treatments. the study found that 
the long-acting insulin analogues, glargine and detemir, have 
only slight clinical advantages over neutral Protamine hagedorn 
(nPh) insulin, but have much higher costs. they do not appear 
cost effective as first-line insulins compared with nPh insulin 
in type 2 diabetes. exenatide, when used as third drug instead 
of progressing immediately to insulin therapy after failure of 
dual oral combination therapy, appears cost-effective relative to 
glargine. however, exenatide appears to be unlikely to be cost-
effective compared with nPh. the gliptins are comparable to the 
glitazones in glycaemic control and costs, but, at present, appear to 
have fewer long-term side effects. the authors concluded that new 
drugs were all clinically effective.
health technol Assess 2010, doi: 10.3310/hta14360 
STUDY 22 (PUBlISHED)
Development of a cost-effectiveness model for optimization of the 
screening interval in diabetic retinopathy screening. 
Published 2015, Scanlon
Under the nhS Diabetic eye Screening Programme, eligible 
people with diabetes are invited annually for digital retinal 
photography screening, to identify those at high risk and requiring 
intervention. this study set out to establish whether moving from 
a fixed annual screening interval, to an interval calculated based 
on individual risk factors, would be cost-effective. the study used 
a modelling approach based on data from four UK regions. this 
found that annual screening was not cost-effective. Screening 
those in low-risk groups every five years, and those in higher-risk 
groups every two years, was found to be most cost-effective. 
health technol Assess 2015, doi: 10.3310/hta19740
STUDY 23 (oNGoING)
Introducing personalised risk based intervals in screening 
for diabetic retinopathy: development, implementation and 
assessment of safety, cost-effectiveness and patient experience. 
Due to publish 2018
this programme grant aims to explore varying the diabetic 
eye disease (retinopathy) screening interval for people with 
diabetes according to their degree of risk, and whether longer 
screening intervals would be acceptable to people at lower risk. 
the programme of work will include use of a whole population 
cohort (about 18,000 people) to measure the risk of progression 
to treatment and visual impairment. Qualitative research methods 




Colour vision testing for diabetic retinopathy: a systematic review 
of diagnostic accuracy and economic evaluation. 
Published 2009, Rodgers
this systematic review examined the diagnostic performance and 
cost-effectiveness of colour vision testing to identify and monitor 
the progression of diabetic retinopathy. twenty-five studies were 
identified, with quality being generally poor. It found insufficient 
evidence to support the use of colour vision testing, alone or in 
combination with retinal photography, as a screening mechanism.
health technol Assess 2009, doi: 10.3310/hta13600
STUDY 25 (oNGoING)
Can automated Diabetic Retinopathy Image Assessment softwares 
replace one or more steps of manual imaging grading and is this 
cost-effective for the NHS Diabetic Eye Screening Programme? 
Due to publish 2016
this observational study will look at the use of software to assess 
images taken during diabetic retinopathy screening, instead of 
manual assessment. this approach could increase the efficiency of 
screening, help identify low risk patients and allow staff to focus 
on assessment of more serious cases. the study will also examine 
cost-effectiveness.
http://www.nets.nihr.ac.uk/projects/hta/112102
STUDY 26 (PUBlISHED) – CoCHRANE 
Blood pressure control for diabetic retinopathy
Published 2015, Do
this review summarised the evidence regarding the effect of 
interventions to control blood pressure on the incidence and 
progression of diabetic retinopathy. the study found 15 trials 
involving almost 15,000 participants (the majority with type 2 
diabetes). the evidence suggested that intervening to lower blood 
pressure in diabetics reduces the incidence of retinopathy but only 
by a modest amount, but it did not appear to slow progression of 
retinopathy. the evidence was of low to moderate quality. Intervening 
to lower blood pressure solely in order to reduce the incidence or 
progression of diabetic retinopathy is probably not justified.
Cochrane Database of Systematic Reviews 2015, doi: 
10.1002/14651858.CD006127.pub2
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STUDY 27 (oNGoING)
What Works to Increase Attendance for Diabetic Retinopathy 
Screening? An Evidence sYnthEsiS (WIDeR-EyeS) An evidence 
synthesis of published and grey literature to identify the 
effectiveness and cost-effectiveness of quality improvement (QI) 
interventions for increasing uptake and ongoing attendance for 
diabetic retinopathy screening 
Due to publish 2017
this study will review the evidence for the best ways of 
encouraging attendance at retinopathy screening and explore the 
reasons for people not attending. this will include interventions 
aimed at increasing both the initial uptake and ongoing 
attendance for diabetic retinopathy screening, whether targeted 
at the individual, healthcare professional or healthcare system. the 
exact nature of different interventions will be described as part of 




Improving the economic value of photographic screening for 
optical coherence tomography-detectable macular oedema: a 
prospective, multicentre, UK study. 
Published 2013, Olson
this study aimed to assess the best of these surrogate markers 
for detecting potentially sight-threatening macular oedema. 
Macular oedema is the more common cause of vision loss in people 
with diabetes. At present, macular oedema is identified during 
screening using a number of surrogate photographic markers. the 
study also examined the use of optical coherence tomography, 
a form of ultrasound imaging. More than 3000 patients were 
recruited across seven centres, and underwent both retinal 
photography and optical coherence tomography. the resulting 
images were analysed to identify the most effective pathways for 
screening for macular oedema. It was found that compared with 
all current manual grading schemes, a fully automated annotation 
grading strategy – which uses an automated detection of patterns 
of surrogate markers – achieves a higher specificity for detecting 
macular oedema. this approach is more cost-effective than more 
sensitive strategies, which tend to increase the costs to the health 
service for only small gains in health outcomes. the addition of 
optical coherence tomography prior to referral resulted in cost 
savings without reducing health benefits.
health technol Assess 2013, doi: 10.3310/hta17510
STUDY 29 (oNGoING)
DIAbetic Macular oedema aNd Diode Subthreshold micropulse 
laser (DIAMoNDS). 
Due to publish 2020
this multi-centre study aims to evaluate the clinical and cost-
effectiveness of Diode Subthreshold Micropulse Laser (DSML) 
compared with standard threshold laser to treat Diabetic Macular 
Oedema (DMO) with Central Retinal thickness (CRt) of < 400 
microns. It will be based in 10 Ophthalmic Units in the UK and will 
involve adults with type 1 or type 2 diabetes and who have DMO 
with a retinal thickness greater than 400 microns. the aim is to 
recruit 266 patients. Patients receiving these treatments and the 
people assessing the response to these treatments will not know 
which type of laser was used. the primary outcome will be the best 
corrected distance visual acuity (BCdvA) in the study eye at 2 years, 
with a range of secondary outcomes including binocular BCdvA, 
central retinal thickness by optical coherence tomography (OCt), 
mean deviation of the humphrey 10-2 visual field, percentage 
of people meeting driving standards, general and visual related 
quality of life, side effects, number of laser treatments needed, 
and need for additional treatment. Cost effectiveness will also 
be evaluated. the research team includes expert clinicians, 
methodologists, statisticians, health economists, and qualitative 
researchers, whilst patients have been involved in the study design.
http://www.nets.nihr.ac.uk/projects/hta/1314204 
STUDY 30 (PUBlISHED)
Pan-retinal photocoagulation and other forms of laser treatment 
and drug therapies for non-proliferative diabetic retinopathy: 
systematic review and economic evaluation
Published 2015, Royle
this study undertook systematic reviews of the evidence in order 
to determine whether it would be worthwhile to intervene with 
pan-retinal photocoagulation (PRP) earlier in diabetic retinopathy, 
at the severe non-proliferative (pre-proliferative) diabetic 
retinopathy stage, rather than wait till the high-risk proliferative 
diabetic retinopathy stage. A second aim was to determine what 
form of laser treatment could be used and whether drug-PRP 
combinations are clinically effective and cost-effective. they 
concluded that, although there have been recent advances in laser 
technologies there is, as yet, no convincing evidence that modern 
lasers are more effective than existing argon lasers and therefore 
they could not recommend a policy of PRP at the severe nPDR 
stage. they also carried out systematic reviews of the efficacy and 
cost effectiveness of using of PRP, with or without anti-vascular 
endothelial growth factor (anti-veGF) drugs or steroid. Overall, 
adjuvant (anti-veGF) or steroid treatment (triamcinolone) reduced 
the adverse effects of PRP.
health technol Assess 2015, doi: 10.3310/hta19510
STUDY 31 (PUBlISHED)
optimal strategies for monitoring kidney disease in diabetes: 
properties of monitoring tests, progression of renal dysfunction 
and impact of treatment. 
Published 2014, Farmer
the aim of this project was to determine the clinical value and 
cost-effectiveness of screening programmes for kidney disease 
in people with diabetes (type 1 and type 2), including assessing 
the current practice of annual screening. Current and alternative 
screening programmes with different screening intervals were 
evaluated using simulation models to determine whether current 
UK annual screening guidelines are cost-effective.
the investigators also aimed to determine whether the 
effectiveness of using angiotensin converting enzyme inhibitors 
(ACei) or angiotensin 2 receptor blockers (A2RB) varied according 
to whether a patient already has kidney disease by conducting a 
review of previous studies. they found that annual screening with 
albumin to creatinine ratio (ACR) appeared to be cost-effective 
to minimise the risk of adverse kidney outcomes for patients with 
type 1 and patients with type 2 diabetes. 
they also showed that, in patients with type 1 diabetes, the 
extent of reduction in renal albumin excretion with ACei and A2RB 
treatment varies with presence or absence of microalbuminuria 
(treatment reduced albumin excretion by two-thirds in patients 
with microalbuminuria, but there was no benefit for patients 
without albuminuria). For people with type 2 diabetes, the relative 
benefit of treatment was approximately the same regardless of the 
presence or absence of microalbuminuria.
health technol Assess 2014, doi: 10.3310/hta18140
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STUDY 32 (PUBlISHED)
A systematic review and individual patient data meta-analysis of 
prognostic factors for foot ulceration in people with diabetes: the 
international research collaboration for the prediction of diabetic 
foot ulcerations (PoDUS)
Published 2015, Crawford
this study was a systematic review and analysis from studies 
that explored the best factors to consider in identifying people at 
risk of foot ulceration. they identified 16 studies and were able 
to analyse individual patient data from ten of those. they found 
that previous history of foot ulceration, inability to feel a 10-g 
monofilament test, at least one absent foot pulse, and longer 
duration with diagnosed diabetes were all predictive of increased 
risk of ulceration.
health technol Assess 2015, doi: 10.3310/hta19570
STUDY 33 (oNGoING)
Implementation of corneal confocal microscopy (CCM) in primary 
care optometry practices for screening and early assessment of 
diabetic neuropathy: a feasibility study
Due to publish 2016
this was the first feasibility and acceptability study of corneal 
confocal microscopy (CCM) in community optometry practices. 
It was conducted alongside routine diabetic eye (retinopathy) 
screening programme appointments. the most common 
complication in diabetes is damage to the nerves in the limbs, 
particularly the feet and legs; this is called diabetic neuropathy. 
Around one in five diabetic patients have diabetic neuropathy and 
it can lead to numbness, pain, loss of sensation, foot ulceration 
and in, some cases, amputation. CCM is a new, non-invasive eye 
test which can detect diabetic neuropathy in limbs in its earliest 
stages. Working with heidelberg engineering, CLAhRC Greater 
Manchester implemented CCM in four optometrist practices, 
recruiting 449 patients to have the screening test. early results 
indicate CCM was acceptable to patients. to be implemented 
in routine practice it would be necessary to explore further 
the required resources and technological improvements, and 
the impact of earlier diagnosis on diabetic management (as no 




Does higher quality of primary healthcare reduce hospital 
admissions for diabetes complications? A national observational 
study. 
Published 2015, Calderón-Larrañaga
the aim of this project was to determine if hospital admission 
rates for diabetes complications were associated with primary care 
diabetes management. An observational study was conducted 
during 2004-2009, involving 8140 general practices in england. 
Diabetes admissions decreased significantly during this period. In 
multivariate regression models, increasing deprivation and diabetes 
prevalence were risk factors for admission, while most healthcare 
covariates, i.e. a larger practice population, better patient-
perceived urgent and non-urgent access to primary care and better 
hbA1c target achievement, were protective. the authors concluded 
that better scheduled primary care access and glycaemic control 
were associated with lower hospital admission rates across most 
complications. they further indicated that the risk of emergency 
hospital admission should be monitored routinely.
Diabetic Medicine 2014, doi: 10.1111/dme.12413
STUDY 35 (PUBlISHED)
Use of hospital admissions data to quantify the burden of 
emergency admissions in people with diabetes mellitus.
Published 2014, Gibbons 
this study examined whether current approaches to identifying 
diabetes-related hospital admissions underestimated the true 
burden on hospital care. hospital episode Statistics data for 
england from 2006 to 2010 was reviewed, focusing on adults 
admitted to emergency departments citing diabetes, looking 
at primary and other diagnoses. During that period, 2,443,046 
admissions were identified and diabetes was the primary diagnosis 
in 6.2% of cases, and as the third diagnosis in 23.1% of cases. 
type 2 diabetes was the most common type (85%). the majority 
of diabetes citations were ‘without complication’ (89.6%). the 
most common primary diagnosis was ‘chest pain, unspecified’ 
(4.1%).the authors concluded that reliance on primary diagnosis 
to identify emergency admissions in people with diabetes largely 
underestimates the true burden placed on hospital care and leads 
to underestimates of effect sizes in studies utilizing admission 
rates as outcome measures. the authors therefore argued that an 
alternative strategy to identify admissions is required.
Diabetic Medicine 2014, doi: 10.1111/dme.12444
STUDY 36 (PUBlISHED)
Non-pharmacological approaches to improving diabetes outcomes
Published 2015 and 2016, Winkley
this small qualitative study involved interviews with people 
newly diagnosed with type 2 diabetes, who had not attended 
structured education, to establish why they had not. the first key 
theme was that patients felt that either structured education had 
not been mentioned at all by their healthcare professional, or that 
the benefits of it had not been clearly explained. Secondly, people 
mentioned practical barriers such as parking, access or timing; 
or preferences relating, for example, to the group nature of the 
session. Finally some participants expressed views relating to a 
perceived sense of shame or stigma relating to their diabetes. they 
had not attended the education session because they were worried 
about telling others of their diagnosis. A related study looked 
at the characteristics of both GP practices, and patients, to see 
whether these were correlated with uptake of education. It found 
that those at higher risk of diabetes complications, such as smokers, 
were less likely to attend, whilst GP practices with better records of 
achieving glycaemic control targets had more patients attending. 
Diabetic Medicine 2014, doi: 10.1111/dme.12556, and Patient 
education and Counseling 2016, doi: 10.1016/j.pec.2015.08.015
STUDY 37 (oNGoING)
Increasing uptake of effective self-management education 
programmes for type 2 diabetes in multi-ethnic primary care 
settings. 
Due to publish 2020 
this project aims to identify why some people are not offered 
education and why some of those who are, do not attend. the 
investigators will develop and try out a package of practical 
solutions for GPs to support more people with type 2 diabetes 
having structured education. this will include offering a choice in 
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STUDY 38 (oNGoING/INTERIM fINDINGS PUBlISHED)
Development, evaluation and implementation of a computer-
based self-management programme for people with type 2 
diabetes. 
Interim findings published 2014, Murray 
this study aims to research, develop, test and implement a 
computer-based self-management programme for people with 
type 2 diabetes. An initial systematic review (see reference below) 
formed the basis of the first stages of the research. the review 
considered the results from 16 randomised controlled trials with 
over 3,500 participants in total. these trials included a range of 
interventions delivered via clinics, the internet and mobile phones. 
Overall, computer-based diabetes self-management interventions 
had a small effect on glycaemic control, but no effect on other 
measures such as depression, quality of life, blood pressure, serum 
lipids, or weight. Interventions delivered via mobile phone, which 
were studied in three trials, achieved a slightly greater effect.
Diabetes Care 2014, doi: 10.2337/dc13-1386 
STUDY 39 (PUBlISHED)
The clinical effectiveness of diabetes education models for Type 2 
diabetes: a systematic review.
Published 2008, Loveman
this review identified 13 studies on educational interventions 
in diabetes, with variable quality of reporting and methodology. 
the findings of these studies were mixed, with some reporting 
significant improvements in diabetic control as a result of 
educational interventions, and others not. Overall, the review 
found that education delivered by a team, with learning 
reinforced through additional points of contact, may offer the best 
opportunity for improving patient outcomes. time, resources and 
a clear programme from the outset may also be factors in success. 
It was not clear what resources would need to be directed at the 
educators themselves to ensure that they can deliver programmes 
successfully. Good quality and long-term studies would be 
beneficial and future research should consider patient education 
within the context of overall diabetes. 
health technol Assess 2008, doi: 10.3310/hta12090 
STUDY 40 (PUBlISHED)
Qualitative review of self-management
Published 2014, Frost; and 2016, Frost
this review of qualitative studies on type 2 diabetes patients’ 
views of self-managing their condition found that having a sense 
of ownership of their management was very important. Ownership 
can be reinforced by the provision of personalised, relevant advice, 
but undermined if professionals do not take account of individual 
beliefs and preferences. too great an emphasis on clinical markers 
such as blood glucose was seen as potentially unhelpful by some, 
who preferred a focus on goals tailored to their needs – for 
example, weight-loss or portion control.
BMC health Services Research 2014, doi: 10.1186/1472-6963-14-348
STUDY 41 (PUBlISHED)
A systematic review and meta-ethnography to identify 
how effective, cost-effective, accessible and acceptable self 
management support interventions are for men with long-term 
conditions (SElf-MAN). 
Published 2015, Galdas
this study reviewed quantitative and qualitative research on the 
effectiveness, cost-effectiveness, accessibility and acceptability of 
self-management support interventions for men with long-term 
conditions. the study looked at all types of long-term condition, 
not just diabetes, and does not present findings specifically relating 
to diabetes. evidence on effectiveness is limited, although there 
was some evidence that multicomponent interventions that include 
physical activity, education or peer support may have a positive 
impact on quality of life in men. there was not enough evidence to 
assess cost-effectiveness. More generally the review found that self-
management support is more likely to be accessible and acceptable 
to men when it is tailored to individual preferences and lifestyles, 
including those relevant to male identities.
health Serv Deliv Res 2015, doi: 10.3310/hsdr03340 
STUDY 42 (PUBlISHED)
Non-pharmacological approaches to improving diabetes outcomes. 
Published 2016, Graves
this qualitative study used semi structured interviews with 
nurses to explore their experiences of training in psychological 
skills in order to support people’s self-management of diabetes. 
the study identified positive aspects such as empowering patients 
and negative aspects such as concerns about over-stepping their 
nursing role and potential degree of support from fellow clinicians.
Primary Care Diabetes 2016, doi: 10.1016/j.pcd.2016.03.001
 STUDY 43 (oNGoING)
A systematic review of psychological interventions to improve 
motivation for self-management in people with type 1 and  
type 2 diabetes. 
Due to publish 2018
this systematic review will look at studies that have examined 
the effectiveness of psychological interventions – such as talking 
therapies – in helping motivate people to manage their diabetes. 
Successful management of diabetes requires commitment and 
motivation from patients, including changing diet, taking exercise, 
checking blood sugar regularly and taking medication. even 
having attended education programmes, many patients struggle to 
manage their diabetes successfully, and may experience negative 
feelings and depression. talking therapies have been used to 
try and help people work out why they are not managing their 
diabetes well, then to support them in challenging negative 
feelings and to become more motivated and confident. this review 
will look at the existing evidence to see if these types of therapies 
are helpful, as well as considering cost-effectiveness.
http://www.nets.nihr.ac.uk/projects/hta/1421310
STUDY 44 (oNGoING)
Managing with learning Disability and Diabetes. 
Due to publish 2016
this study is exploring whether it is feasible to conduct a trial 
of a support intervention for people with learning disability and 
diabetes. the intervention consists of a manual and associated 
support to help people manage their condition, both by themselves 




Self-monitoring of blood glucose in type 2 diabetes.
Published 2010, Clar
this systematic review explored whether supporting patients with 
type 2 diabetes to monitor their own blood glucose is effective and 
cost-effective. the review included 30 trials, although few were 
of high quality. Comparing self-monitoring with usual care found 
a small reduction in blood glucose, though possibly not enough 
to be clinically significant. there was a similar small difference 
when comparing self-monitoring alone, with self-monitoring with 
education. Some patients found self-monitoring to be empowering 
and reassuring, but for others it led to adverse psychological effects 
including guilt and depression.
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there was a lack of education for patients in how to interpret 
and use the data, and a lack of interest in the results from 
healthcare professionals. Overall the study found that self-
monitoring is likely to be of limited clinical effectiveness in 
improving glycaemic control, and is therefore unlikely to be cost-
effective. however there were signs that self-monitoring could 
be more effective if accompanied by appropriate education for 
patients and professionals on how to respond to data gleaned 
from self-monitoring; and if patients were able to self-adjust drug 
treatment. More research would be needed to establish the type of 
education and support that is most helpful.
health technol Assess 2010, doi: 10.3310/hta14120 
STUDY 46 (PUBlISHED)
What is the evidence for the effectiveness, appropriateness, and 
feasibility of group clinics for patients with chronic conditions?: a 
systematic review.
Published 2015, Booth
Group clinics deliver care to small groups of patients with the 
same condition at the same time rather than each patient meeting 
a doctor on a one-to-one basis. this review aimed to find out 
whether or not group clinics worked better and were a better use 
of resources than one-to-one appointments. It also investigated 
what patients and health professionals thought about group 
clinics. Several studies looked at whether or not group clinics were 
cost effective but the results were unclear. Most studies took place 
in the USA. 
the study found that most research focused on people with 
diabetes and that group clinics were better than individual 
appointments for improving some measures of diabetic control. 
Group clinics also improved the quality of life of patients. however, 
they did not find any other improvements for patients. Patients 
and health professionals tended to view group clinics positively, 
but the research did not include much on the views of people who 
disliked group clinics. 
health Serv Deliv Res 2015, doi: 10.3310/hsdr03460
STUDY 47 (PUBlISHED)
The potential impact of displacing sedentary time in adults with 
type 2 diabetes.
Published 2015, Falconer
Sedentary time, in particular prolonged unbroken periods, 
is detrimental to health and reduces the time spent in any 
form of light physical activity. this study looked at the impact 
of reallocating time from sedentary behaviour to more active 
behaviour in people with type 2 diabetes. this involved 
undertaking measurement and modelling on data from over 500 
patients enrolled in another diabetes trial. the study found that 
breaking up a period of 30 minutes of sedentary time into shorter 
sedentary bouts, interspersed with light activity, had a positive 
impact on body mass index and waist circumference. the effects 
were stronger if the 30 minutes of sedentary time was replaced 
with light physical activity. these findings suggest that simply 
breaking up inactive time into shorter bouts, or adding small 
amounts of light physical activity, can be beneficial for people  
with type 2 diabetes.
Medicine and Science in Sports and exercise 2015, doi: 10.1249/
MSS.0000000000000651
STUDY 48 (PUBlISHED)
Breaking Up Prolonged Sitting With Standing or Walking 
Attenuates the Postprandial Metabolic Response in 
Postmenopausal Women: A Randomized Acute Study
Published 2016, Henson
this study aimed to establish whether breaking up prolonged 
periods of sitting with regular short bouts of standing or 
walking would have a beneficial effect for women at risk of 
type 2 diabetes. twenty-two women – all overweight or obese, 
postmenopausal and with raised blood glucose – each participated 
in two activities: prolonged, unbroken sitting or prolonged sitting 
broken up with 5 minutes of standing or walking every 30 minutes. 
Both standing and walking had significant, positive effects on 
blood glucose and other markers of metabolic health.
Diabetes Care 2016, doi: 10.2337/dc15-1240
STUDY 49 (PUBlISHED)
The effects of high-intensity interval training on glucose 
regulation and insulin resistance: a meta-analysis
Published 2015, Jelleyman
this review looked at the results of 50 studies exploring the 
impact of high-intensity interval training on markers of glucose 
regulation and insulin resistance. high-intensity interval training is 
an exercise regime which involves short but very vigorous bouts of 
exercise. the review found that this form of training was effective 
at improving measures of insulin resistance, compared with both 
not exercising, and continuous moderate exercise. For people 
with type 2 diabetes, there was also a reduction in blood glucose. 
however, study quality was poor and the interventions studied 
were diverse, suggesting that further research is needed to confirm 
these findings.
Obesity Reviews 2015, doi: 10.1111/obr.12317
STUDY 50 (PUBlISHED)
Diet or diet plus physical activity versus usual care in patients with 
newly diagnosed type 2 diabetes: the Early ACTID randomised 
controlled trial.
Published 2011, Andrews
this randomised controlled trial, involving over 500 participants, 
allocated patients to either usual care, a dietary intervention 
or dietary intervention plus exercise. the dietary intervention 
involved a consultation every 3 months with monthly nurse 
support. Glycaemic control improved in both the diet group, and 
the diet plus activity group, at 6 months and this was sustained 
at 12 months. Improvements were also seen in weight and insulin 
resistance. Adding activity to the dietary intervention did not seem 
to confer additional benefit.
Lancet 2011, doi: 10.1016/S0140-6736(11)60442-X 
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